partial epilepsy: A seizure caused by a localized disorder.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
518448 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
8713 |
6. Filter based on genotype QC (FinnGen only) |
8713 |
Control definitions (FinnGen only)
- Control exclude
- G6_EPLEPSY
- Control conditions
- not GE
Extra metadata
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
Focal epilepsy, strict definition
based on the number of shared cases.
Similar with more cases:
- Focal epilepsy
- Epilepsy
- Episodal and paroxysmal disorders
- Neurological diseases
- Neurological diseases, wide definition
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 83361 | 38369 | 44332 |
| Only index persons | 69676 | 32994 | 36682 |
| Unadjusted period prevalence (%) | |||
| Whole population | 1.17 | 1.10 | 1.24 |
| Only index persons | 1.31 | 1.21 | 1.40 |
| Median age at first event (years) | |||
| Whole population | 53.68 | 53.75 | 53.47 |
| Only index persons | 52.12 | 52.25 | 52.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 8713 | 4298 | 4415 |
| Unadjusted period prevalence (%) | 1.71 | 1.47 | 1.95 |
| Median age at first event (years) | 54.34 | 49.89 | 58.67 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 7820
- Matched controls
- 78201
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N03AG01
ATC
valproic acid; systemic, rectal
25.4
323.0
2575
1482
N03AX14
ATC
levetiracetam; systemic
327.3
323.0
2732
128
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
+∞
323.0
441
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
323.0
1335
*
AA1AD
NOMESCO Finland
CT of head and brain
5.3
323.0
3524
10526
N05BA01
ATC
diazepam; systemic, rectal
3.8
323.0
1686
5214
R56.8
ICD-10 Finland
Other and unspecified convulsions
43.4
323.0
2989
1098
N88
ICPC
Epilepsy
632.5
323.0
477
8
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
16384.0
323.0
3165
*
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
5457.8
323.0
521
*
N03AX18
ATC
lacosamide; systemic
1421.4
323.0
770
6
N03AB02
ATC
phenytoin; systemic
62.4
323.0
622
108
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
+∞
323.0
322
*
G40.10
ICD-10 Finland
Simple partial seizures
11086.6
323.0
983
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
8.3
323.0
1733
2591
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.6
323.0
1879
6361
N03AX09
ATC
lamotrigine; oral
9.5
323.0
1054
1264
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9729.1
323.0
877
*
N03AF01
ATC
carbamazepine; oral, rectal
22.0
323.0
1982
1188
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
+∞
323.0
1092
*
G40
ICD-10 Finland
Epilepsy
1356.1
323.0
738
6
N05BA09
ATC
clobazam; oral
697.5
323.0
583
9
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
323.0
935
*
XA800
NOMESCO Finland
Neuropsychological investigation
8.7
323.0
933
1200
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
323.0
2883
*
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
323.0
372
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
39.6
323.0
554
150
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
12845.5
323.0
2629
*
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
+∞
323.0
323
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
323.0
6405
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
120.0
323.0
388
34
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
6.1
323.0
1249
2357
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
2880.9
323.0
811
*
N03AF02
ATC
oxcarbazepine; oral
216.8
323.0
3305
263
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.5
323.0
1379
2936
G40.9
ICD-10 Finland
Epilepsy, unspecified
3969.9
323.0
3153
12
G40.89
ICD-10 Finland
Other epilepsy
1674.5
322.7
312
*
L01AX03
ATC
temozolomide; systemic
49.5
309.6
378
80
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.5
306.7
664
758
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
21.2
293.9
444
221
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.9
282.3
1313
3834
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.3
276.3
1138
2969
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
10.6
246.8
499
498
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
40.1
239.6
305
79
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
+∞
236.6
226
*
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
18.6
219.8
347
195
G40.6
ICD-10 Finland
Grand mal seizures, unspecified (with or without petit mal)
1093.2
218.7
213
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.8
209.9
1602
6594
N05CD08
ATC
midazolam; nasal, systemic
8.6
209.6
479
592
N03AX11
ATC
topiramate; oral
8.8
209.4
471
567
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.6
196.7
981
2975
H02AB02
ATC
dexamethasone; systemic
3.3
192.3
1089
3642
N03AX23
ATC
brivaracetam; systemic
1831.8
176.6
171
*
R55
ICD-10 Finland
Syncope and collapse
3.0
172.9
1150
4282
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
76.2
169.4
193
26
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.9
166.5
583
1262
34532
ICD-8 Finland
Epilepsy, Partialis (focalis) generalisata
+∞
164.1
157
*
N03AE01
ATC
clonazepam; systemic
4.0
163.6
708
1887
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
158.8
1523
7010
3454B
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]
+∞
157.8
151
*
ZXC95
NOMESCO Finland
Use of surgical navigator
13.0
155.2
282
224
34530
ICD-8 Finland
Epilepsy, Psychomotorica
+∞
154.7
148
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
11.9
154.0
292
254
34599
ICD-8 Finland
Epilepsy, Other and unspecified
+∞
153.6
147
*
N03AX22
ATC
perampanel; oral
1542.8
152.5
148
*
K90
ICPC
Stroke/cerebrovascular accident
6.2
152.2
431
724
R41.0
ICD-10 Finland
Disorientation, unspecified
5.6
143.1
440
819
XA400
NOMESCO Finland
EEG
23.1
142.8
209
93
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
14.3
139.5
243
175
N03AX15
ATC
zonisamide; oral
56.5
139.4
166
30
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
25.3
139.2
198
80
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
11.7
135.8
259
228
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
9.1
135.4
296
337
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
134.6
2433
14672
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
5.2
133.1
440
890
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
133.0
2014
11323
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
+∞
131.6
126
*
T90.5
ICD-10 Finland
Sequelae of intracranial injury
10.9
130.0
257
243
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
118.7
129.4
140
12
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
14.2
127.1
222
161
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
126.2
912
3535
AA1BD
NOMESCO Finland
Extensive CT of head and brain
5.8
125.8
378
683
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
150.3
125.6
133
9
G40.0
ICD-10 Finland
Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset
+∞
125.3
120
*
G41.0
ICD-10 Finland
Grand mal status epilepticus
149.1
124.6
132
9
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.3
123.8
490
1194
7803A
ICD-9 Finland
General symptoms, Convulsions
13.7
122.7
217
162
3459X
ICD-9 Finland
Epilepsy, unspecified
+∞
121.1
116
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
7.6
120.3
293
397
TAB00
NOMESCO Finland
Lumbar puncture
4.1
119.8
500
1279
H53.4
ICD-10 Finland
Visual field defects
6.5
118.0
320
506
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
18.1
117.4
186
105
A28
ICPC
Limited function/disability NOS
2.3
116.6
1268
6114
130
Kela drug reimbursment
Malignant tumour
2.8
113.2
791
2989
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
17.0
111.2
180
108
N06AB04
ATC
citalopram; systemic
2.0
111.0
1686
9379
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.9
109.6
739
2729
XF400
NOMESCO Finland
ECG with 12 standard connections
2.1
105.9
1419
7479
R51.80
ICD-10 Finland
Headache
2.2
103.6
1223
6097
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.1
100.0
611
2109
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
6.7
99.6
265
408
G41.2
ICD-10 Finland
Complex partial status epilepticus
152.0
99.3
105
7
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
7.7
98.6
238
318
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
39.4
97.5
124
32
N05AX08
ATC
risperidone; systemic
2.7
97.3
740
2935
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
11.1
96.5
188
173
N03AG04
ATC
vigabatrin; oral
949.8
96.2
94
*
R47.0
ICD-10 Finland
Dysphasia and aphasia
10.8
95.6
189
179
R4150
NOMESCO Finland
Neuropsychological rehabilitation
13.4
95.5
170
129
N05AH04
ATC
quetiapine; oral
2.1
94.4
1311
6977
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
144.6
94.2
100
7
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
5.8
92.8
276
491
R4120
NOMESCO Finland
Occupational therapy
2.9
92.5
612
2224
WX892
NOMESCO Finland
Monitored bed care
2.7
92.2
713
2850
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
92.1
1633
9537
S06.3
ICD-10 Finland
Focal brain injury
7.9
91.8
217
281
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
90.2
674
2640
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
7.4
90.0
223
310
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
11.2
89.6
174
159
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
5.8
89.2
265
471
N18
ICPC
Paralysis/weakness
5.9
89.1
262
460
F02.89*G40.9
ICD-10 Finland
Dementia in epilepsy
+∞
88.7
85
*
S06.0
ICD-10 Finland
Concussion
2.3
88.5
916
4267
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
8.9
86.8
190
217
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.5
85.3
422
1243
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.2
84.9
982
4816
R53
ICD-10 Finland
Malaise and fatigue
1.9
84.5
1570
9284
N03AF04
ATC
eslicarbazepine; oral
+∞
83.5
80
*
L28
ICPC
Limited function/disability (L)
2.0
81.8
1201
6502
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
11.1
81.7
159
146
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
280.9
81.7
83
*
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
67.8
81.5
94
14
A06AD11
ATC
lactulose; oral
2.0
79.8
1150
6174
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
76.0
79.3
90
12
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
10.9
79.0
155
145
F05.9
ICD-10 Finland
Delirium, unspecified
5.6
78.6
240
441
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
78.0
3113
22932
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
25.7
77.4
109
43
181
Kela drug reimbursment
Retigabine and vigabatrin
+∞
77.2
74
*
N07
ICPC
Convulsion/seizure
30.1
77.0
104
35
W19
ICD-10 Finland
Unspecified fall
2.3
76.8
810
3795
R42
ICD-10 Finland
Dizziness and giddiness
1.8
76.4
1570
9559
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
2.7
76.3
566
2200
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.2
76.1
421
1349
ZXC40
NOMESCO Finland
Use of ultrasound
11.1
76.1
148
136
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.6
75.9
605
2452
N05BA04
ATC
oxazepam; oral
1.7
75.7
1780
11308
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
13.9
73.9
129
94
WX882
NOMESCO Finland
High dependency care
3.6
73.7
356
1028
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
+∞
73.0
70
*
SPAT1229
SPAT
Assessment of need for aid
2.4
73.0
663
2879
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
9.6
72.5
152
161
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
+∞
69.9
67
*
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.0
69.7
178
259
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
15.2
69.6
117
78
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.5
68.4
565
2333
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
19.5
67.9
104
54
34539
ICD-8 Finland
Epilepsy, Partialis (focalis) NUD
+∞
67.8
65
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.0
66.6
191
325
K91
ICPC
Cerebrovascular disease
6.4
66.4
182
292
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
66.3
816
4083
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
228.5
66.3
68
*
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
65.7
1210
7063
AAF00
NOMESCO Finland
Ventriculostomy
10.8
64.3
126
118
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
37.7
64.2
82
22
N06AX11
ATC
mirtazapine; oral
1.6
63.9
2175
15189
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.7
63.4
288
790
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
3.6
63.2
301
859
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
6.2
63.0
176
290
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
62.8
584
2562
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.2
62.3
658
3069
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
21.6
62.2
92
43
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
62.2
1432
8965
S01.0
ICD-10 Finland
Open wound of scalp
2.3
61.5
603
2717
WX872
NOMESCO Finland
Intensive care
2.7
60.8
436
1657
A04AA02
ATC
granisetron; systemic, transdermal
2.6
60.7
476
1906
SPAT1216
SPAT
Assessment of functional ability
1.8
60.6
1106
6418
N05AH03
ATC
olanzapine; systemic
2.5
60.1
490
2002
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
67.4
58.2
67
10
XCK00
NOMESCO Finland
Perimetry
2.4
57.5
531
2320
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
57.4
1083
6346
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
52.7
56.9
68
13
Z51.5
ICD-10 Finland
Palliative care
2.5
56.8
477
1981
XX3DW
NOMESCO Finland
Time consuming IT work
2.1
56.6
737
3765
G40.51
ICD-10 Finland
Epileptic seizures related to alcohol
+∞
56.3
54
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.4
56.2
127
154
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.2
56.0
307
976
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.9
56.0
245
651
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
51.9
55.9
67
13
S06.2
ICD-10 Finland
Diffuse brain injury
6.4
55.8
151
239
C03CA01
ATC
furosemide; systemic
1.6
55.7
1962
13723
N02AA05
ATC
oxycodone; systemic
1.8
55.6
1021
5925
WX730
NOMESCO Finland
Conventional respirator
4.8
55.0
191
407
N28
ICPC
Limited function/disability (N)
5.1
54.7
178
353
AAK00
NOMESCO Finland
Cranioplasty
37.2
54.7
70
19
N05CF01
ATC
zopiclone; oral
1.5
54.5
2184
15736
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.2
54.2
583
2738
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
11.5
53.7
102
90
N02BE01
ATC
paracetamol; systemic, rectal
1.5
53.6
6114
54728
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
52.5
1187
7347
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
52.4
906
5140
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
7.4
52.3
128
176
N06AB10
ATC
escitalopram; oral
1.7
52.2
1336
8574
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
4.4
51.9
196
455
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
8.9
51.9
113
129
R40.2
ICD-10 Finland
Coma, unspecified
7.0
51.6
131
190
R4130
NOMESCO Finland
Speech therapy
3.8
51.4
227
608
G40.7
ICD-10 Finland
Petit mal, unspecified, without grand mal seizures
262.3
51.1
52
*
3455A
ICD-9 Finland
Epilepsy, Partial epilepsy, without mention of impairment of consciousness
+∞
51.1
49
*
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
50.0
1321
8537
3454X
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]
+∞
50.0
48
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
32.7
49.4
65
20
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
6.7
49.4
129
195
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
49.3
443
1903
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
70.3
49.1
56
8
SPAT1254
SPAT
Administration of medicine
1.7
49.0
1092
6716
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.5
48.8
398
1625
N05CD07
ATC
temazepam; oral
1.8
48.4
866
4966
R50.9
ICD-10 Finland
Fever, unspecified
1.7
48.0
1029
6254
AAJ20
NOMESCO Finland
Excision of epileptic focus
+∞
47.9
46
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
5.4
47.7
148
279
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
26.6
47.6
66
25
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
76.3
47.0
53
7
N29
ICPC
Neurological sympt/complt other
3.9
46.6
198
514
G41.8
ICD-10 Finland
Other status epilepticus
60.4
46.3
54
9
N05AA02
ATC
levomepromazine; systemic
2.7
45.9
336
1291
34533
ICD-8 Finland
Epilepsy, Partialis (focalis) alia
+∞
45.9
44
*
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
45.8
1455
9846
R1260
NOMESCO Finland
Evaluation of communicative skills
4.2
45.8
179
430
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
5.5
45.4
138
254
G91.0
ICD-10 Finland
Communicating hydrocephalus
9.9
45.1
92
94
B01AA03
ATC
warfarin; systemic
1.6
44.9
1377
9234
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
44.1
948
5757
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
43.8
652
3497
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
96.6
43.8
48
5
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.4
43.6
219
653
A02BC02
ATC
pantoprazole; systemic
1.4
43.5
4322
36736
N03AX12
ATC
gabapentin; oral
1.7
43.4
1014
6309
WF002
NOMESCO Finland
Radical radiotherapy
2.4
43.3
385
1645
R56.0
ICD-10 Finland
Febrile convulsions
9.5
43.1
90
96
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
42.6
636
3410
N19
ICPC
Speech disorder
4.2
42.6
169
412
SPAT1234
SPAT
Support of social functional capacity
2.3
42.4
401
1766
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
11.2
42.4
81
73
P20
ICPC
Memory disturbance
1.8
42.0
790
4594
AA5PD
NOMESCO Finland
CT examination of brain pefusion
6.7
41.8
109
165
B01AC04
ATC
clopidogrel; oral
1.7
41.2
1046
6654
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
16.1
41.1
67
42
AA5FG
NOMESCO Finland
Functional MRI examination of brain with high intensity magnet
144.1
40.8
43
*
A86
ICD-10 Finland
Unspecified viral encephalitis
9.4
40.2
84
90
R4110
NOMESCO Finland
Physiotherapy
1.5
40.0
1758
12768
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
41.0
39.3
49
12
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
9.6
39.2
81
85
M03BX01
ATC
baclofen; systemic
4.0
39.2
163
416
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
39.1
1813
13305
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
4.2
38.9
152
366
N05BA06
ATC
lorazepam; systemic, sublingual
2.3
38.8
377
1683
PA7BD
NOMESCO Finland
CT angiography of neck and brain
3.8
38.7
171
460
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
38.7
563
2988
SPAT1301
SPAT
No procedures
1.4
38.6
2164
16481
G40.80
ICD-10 Finland
Epilepsy with continuous EEG spike-waves during slow wave sleep
+∞
38.6
37
*
R11
ICD-10 Finland
Nausea and vomiting
1.9
38.2
578
3114
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
38.2
1368
9478
N99
ICPC
Neurological disease other
4.8
37.6
129
273
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.0
37.3
122
245
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
49.1
36.6
44
9
G40.50
ICD-10 Finland
Epilepsia partialis continua [Kozhevnikof]
+∞
36.5
35
*
G40.59
ICD-10 Finland
Other special epileptic syndromes
+∞
36.5
35
*
R1250
NOMESCO Finland
Evaluation of functional capability
3.3
36.5
188
573
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.7
36.2
259
983
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
11.4
36.1
68
60
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
35.9
352
1577
RS222
NOMESCO Finland
NA
4.3
35.5
135
317
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
5.5
35.5
107
196
F29
ICD-10 Finland
Unspecified nonorganic psychosis
2.5
35.1
277
1112
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
14.0
35.0
60
43
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.4
34.7
299
1255
R25.2
ICD-10 Finland
Cramp and spasm
3.1
34.6
193
624
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
34.4
790
4869
N74
ICPC
Malignant neoplasm nervous system
39.3
34.3
43
11
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
338.6
33.9
34
*
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
22.4
33.9
49
22
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
9.3
33.9
71
77
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
175.7
33.7
35
*
N03AX16
ATC
pregabalin; oral
1.5
33.7
1454
10462
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
120.5
33.7
36
*
SPAT1240
SPAT
Therapeutic discussion
1.7
33.6
687
4091
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
33.0
439
2249
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.2
33.0
180
573
R41.3
ICD-10 Finland
Other amnesia
2.8
32.3
213
768
34598
ICD-8 Finland
Epilepsy, Alia definita
+∞
32.3
31
*
A04
ICPC
Weakness/tiredness general
1.6
32.2
849
5436
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
23.1
32.1
46
20
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.5
32.1
265
1090
N03AG06
ATC
tiagabine; oral
318.3
31.9
32
*
A04AA01
ATC
ondansetron; systemic, rectal
2.0
31.8
438
2276
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
4.9
31.3
105
218
AAJ99
NOMESCO Finland
Other operation for epilepsy
+∞
31.3
30
*
N06AX16
ATC
venlafaxine; oral
1.6
31.0
821
5259
N05AD01
ATC
haloperidol; systemic
2.6
30.8
236
931
B01AC07
ATC
dipyridamole; systemic
2.2
30.8
342
1626
H02AB09
ATC
hydrocortisone; systemic
2.8
30.7
203
733
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
30.6
457
2445
AEA50
NOMESCO Finland
Adjustment of implanted neurostimulator
10.4
30.5
60
58
F10.20
ICD-10 Finland
Alcohol dependence currently independent
3.2
30.4
168
540
F80.1
ICD-10 Finland
Expressive language disorder
4.7
30.1
104
223
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.2
30.0
309
1419
H47.2
ICD-10 Finland
Optic atrophy
7.9
30.0
69
88
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
29.9
675
4132
G72.8
ICD-10 Finland
Other specified myopathies
3.7
29.9
136
377
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
9.6
29.7
61
64
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
34.7
29.6
38
11
I63.8
ICD-10 Finland
Other cerebral infarction
5.3
29.6
92
176
N76
ICPC
Neoplasm nervous system unspecified
19.2
29.1
44
23
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
40.2
28.9
36
9
C08CA01
ATC
amlodipine; oral
1.4
28.9
2175
17262
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.2
28.8
306
1426
N30.0
ICD-10 Finland
Acute cystitis
1.6
28.6
842
5536
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
19.6
28.6
43
22
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
8.5
28.6
63
75
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
3.8
28.4
123
327
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.0
28.3
171
585
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
4.1
28.2
111
271
G91.1
ICD-10 Finland
Obstructive hydrocephalus
8.1
28.2
64
80
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
8.1
28.2
64
80
WX110
NOMESCO Finland
Local anesthesy
1.3
28.2
4656
41401
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
19.6
27.3
41
21
AAJ15
NOMESCO Finland
Hippocampectomy
+∞
27.1
26
*
G04.9
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis, unspecified
9.7
27.1
55
57
WX704
NOMESCO Finland
Intubation
1.8
26.9
461
2587
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
4.4
26.9
99
227
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
26.8
744
10731
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
26.8
2121
16926
G41.1
ICD-10 Finland
Petit mal status epilepticus
75.4
26.8
30
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
41.4
26.7
33
8
9450/3-C71.1
ICD-O-3
Oligodendroglioma, NOS, of frontal lobe
271.9
26.7
27
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
26.7
1901
14916
GBB00
NOMESCO Finland
Tracheostomy
4.1
26.6
106
262
U04
ICPC
Incontinence urine
2.2
26.4
289
1365
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.1
26.4
301
1449
N80
ICPC
Head injury other
3.2
26.2
141
446
F03
ICD-10 Finland
Unspecified dementia
2.2
26.2
271
1249
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.9
26.2
164
575
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
26.1
1773
13791
R25.1
ICD-10 Finland
Tremor, unspecified
2.5
26.1
203
810
G40.52
ICD-10 Finland
Epileptic seizures related to drugs
+∞
26.0
25
*
G40.8
ICD-10 Finland
Other epilepsy
+∞
26.0
25
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
26.0
267
1227
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.5
25.9
125
364
H03AA01
ATC
levothyroxine sodium; systemic
1.4
25.9
1350
10020
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.7
25.9
529
3143
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
13.3
25.9
45
34
C07AB07
ATC
bisoprolol; oral
1.3
25.8
2931
24631
SPAT1053
SPAT
Memory test
1.5
25.7
887
6047
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.1
25.7
144
469
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
93.7
25.6
28
*
W10
ICD-10 Finland
Fall on and from stairs and steps
2.1
25.5
315
1566
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
9.2
25.3
53
58
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.4
25.3
218
920
N05AF03
ATC
chlorprothixene; systemic
2.6
25.2
185
715
AAK80
NOMESCO Finland
Partial excision of skull cap
35.7
25.2
32
9
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
25.1
1085
7763
Z75.5
ICD-10 Finland
Holiday relief care
5.0
24.9
80
160
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
14.1
24.8
42
30
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.2
24.8
135
432
X58
ICD-10 Finland
Exposure to other specified factors
1.5
24.7
862
5887
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
24.7
260
1209
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
24.6
870
5961
E87.6
ICD-10 Finland
Hypokalaemia
2.4
24.6
210
881
WYA20
NOMESCO Finland
Home visit
3.3
24.5
125
381
S22.3
ICD-10 Finland
Fracture of rib
1.8
24.4
409
2279
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
12.7
24.3
43
34
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
24.2
462
2688
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
15.7
24.0
39
25
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
56.2
24.0
28
5
C71.3
ICD-10 Finland
Malignant neoplasm: Parietal lobe
56.2
24.0
28
5
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
24.0
23
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
2.6
23.9
184
731
F83
ICD-10 Finland
Mixed specific developmental disorders
4.7
23.9
82
176
S06.4
ICD-10 Finland
Epidural haemorrhage
12.8
23.8
42
33
N06AX03
ATC
mianserin; oral
2.0
23.8
300
1506
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.7
23.7
548
3375
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
23.6
281
1376
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
13.3
23.6
41
31
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.7
23.6
468
2755
A29
ICPC
General symptom/complaint other
1.6
23.6
673
4382
R46.8
ICD-10 Finland
Other symptoms and signs involving appearance and behaviour
16.9
23.5
37
22
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
23.7
23.4
33
14
S18
ICPC
Laceration/cut
1.3
23.4
2617
21857
ZXM40
NOMESCO Finland
Use of fluorescent substance
19.5
23.4
35
18
AAC40
NOMESCO Finland
Extirpation of intracranial arterio-venous malformation
33.4
23.3
30
9
I95.1
ICD-10 Finland
Orthostatic hypotension
2.3
23.3
222
986
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
4.2
23.3
89
213
S72.0
ICD-10 Finland
Fracture of neck of femur
2.2
23.2
250
1175
N06AB06
ATC
sertraline; oral
1.6
23.2
641
4138
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.0
23.1
133
442
G81.1
ICD-10 Finland
Spastic hemiplegia
14.0
23.0
39
28
96610
ICD-8 Finland
Adverse effect of anticonvulsants, Hydantoin derivatives
+∞
22.9
22
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
22.9
528
3249
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.6
22.8
175
694
JN4BD
NOMESCO Finland
Extensive body CT
1.6
22.7
657
4289
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
22.6
650
4239
N07BB01
ATC
disulfiram; oral
2.0
22.6
278
1382
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
20.7
22.5
33
16
N05AH02
ATC
clozapine; systemic
2.9
22.4
137
475
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.2
22.2
240
1128
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.9
22.2
332
1779
A41.9
ICD-10 Finland
Sepsis, unspecified
2.1
22.2
245
1163
F10.24
ICD-10 Finland
Alcohol depence active use
3.4
22.2
110
329
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
6.2
22.1
60
98
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
18.0
22.1
34
19
Z00.0
ICD-10 Finland
General medical examination
1.4
22.1
1136
8388
-
ICD-10 Finland
NA
2.6
22.0
167
657
N05AB03
ATC
perphenazine; systemic, rectal
2.2
22.0
233
1086
PA2AD
NOMESCO Finland
CT angiography of brain
5.8
21.9
62
107
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
6.6
21.8
56
85
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
4.0
21.8
88
222
G45.4
ICD-10 Finland
Transient global amnesia
2.6
21.8
158
606
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
4.9
21.8
72
149
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
4.5
21.8
77
171
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
21.8
479
2907
C10AA01
ATC
simvastatin; oral
1.3
21.7
2587
21730
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
17.1
21.7
34
20
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
20.1
21.6
32
16
SPAT1252
SPAT
Overall medication plan or its review
1.7
21.5
424
2489
H53.2
ICD-10 Finland
Diplopia
2.3
21.4
204
908
D32.03
ICD-10 Finland
Benign meningioma in ventricles
16.3
21.3
34
21
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
10.6
21.3
41
39
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
13.9
21.2
36
26
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
7.7
21.2
49
64
F44.5
ICD-10 Finland
Dissociative convulsions
50.1
21.1
25
5
R60.0
ICD-10 Finland
Localized oedema
1.6
21.1
636
4197
F06.9
ICD-10 Finland
Unspecified mental disorder due to brain damage and dysfunction and to physical disease
8.4
21.0
46
55
G93.0
ICD-10 Finland
Cerebral cysts
7.1
21.0
51
72
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
20.8
1728
13795
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
3.9
20.5
85
220
ZXA05
NOMESCO Finland
Left side
1.3
20.4
1515
11884
EBA00
NOMESCO Finland
Extraction of tooth
1.3
20.4
2075
17040
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
6.4
20.3
53
83
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.6
20.3
149
578
ZXA00
NOMESCO Finland
Right side
1.3
20.0
1611
12790
AAA10
NOMESCO Finland
Biopsy through craniotomy
17.3
20.0
31
18
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
17.3
20.0
31
18
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
19.9
626
4167
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
3.9
19.8
81
207
P29
ICPC
Psychological sympt/compl other
1.8
19.8
333
1858
B01AB05
ATC
enoxaparin; parenteral
1.3
19.8
1768
14241
G40.01
ICD-10 Finland
Pediatric epilepsy with occipital EEG paroxysms
+∞
19.8
19
*
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.6
19.7
142
544
2152
FHL
Extraction, big brain
13.1
19.6
34
26
9450/3-C71.9
ICD-O-3
Oligodendroglioma, NOS, of brain, NOS
200.4
19.6
20
*
AAU00
NOMESCO Finland
Removal of implant or external fixation device from skull
200.4
19.6
20
*
N05AD03
ATC
melperone; systemic
3.2
19.5
103
324
F05.8
ICD-10 Finland
Other delirium
4.5
19.4
69
155
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
10.6
19.3
37
35
F10.41
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol with seizures
10.0
19.3
38
38
Z50.5
ICD-10 Finland
Speech therapy
2.9
19.3
122
432
F20.9
ICD-10 Finland
Schizophrenia, unspecified
2.6
19.2
143
559
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
31.3
19.2
25
8
N05BA12
ATC
alprazolam; oral
1.6
19.2
576
3795
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
3.1
19.1
106
346
D21
ICPC
Swallowing problem
3.1
18.9
106
348
N03AA02
ATC
phenobarbital; systemic
34.4
18.9
24
7
RS221
NOMESCO Finland
NA
2.9
18.9
115
399
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
5.2
18.8
58
112
P15
ICPC
Chronic alcohol abuse
2.3
18.8
175
771
9401/3-C71.9
ICD-O-3
Astrocytoma, anaplastic, NOS, of brain, NOS
+∞
18.7
18
*
34500
ICD-8 Finland
Epilepsy, """"Petit mal""""
+∞
18.7
18
*
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
3.2
18.7
99
312
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
18.7
652
4443
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
70.0
18.7
21
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
18.6
391
2341
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
18.6
360
2105
F06.32
ICD-10 Finland
Organic depression
10.3
18.6
36
35
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
20.8
18.6
27
13
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
6.2
18.4
49
79
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.5
18.3
624
4229
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
2.1
18.3
217
1065
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.1
18.3
101
329
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
18.3
821
5899
N05AX12
ATC
aripiprazole; systemic
2.0
18.1
226
1129
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.9
18.1
110
379
OAB43
SPAT
NA
0.7
18.0
457
6741
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
18.0
429
2665
2161
FHL
Neck ligation, big brain
6.2
17.9
48
78
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
32.9
17.9
23
7
R33
ICD-10 Finland
Retention of urine
1.6
17.9
468
2979
A07
ICPC
Coma
7.4
17.8
42
57
I61
ICD-10 Finland
Intracerebral haemorrhage
16.5
17.8
28
17
N06DA03
ATC
rivastigmine; oral, transdermal
2.1
17.8
212
1042
J01DB01
ATC
cefalexin; oral
1.3
17.8
5641
52624
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
4.8
17.8
59
124
R47.1
ICD-10 Finland
Dysarthria and anarthria
3.8
17.7
74
194
AAA35
NOMESCO Finland
Insertion of subdural electrodes
+∞
17.7
17
*
F01.9
ICD-10 Finland
Vascular dementia, unspecified
3.2
17.7
94
298
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.8
17.7
117
426
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
6.0
17.6
48
80
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
3.0
17.5
102
344
Z02.7
ICD-10 Finland
Issue of medical certificate
1.7
17.5
359
2136
J01EA01
ATC
trimethoprim; systemic
1.3
17.5
1431
11362
G44.2
ICD-10 Finland
Tension-type headache
1.5
17.4
722
5099
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
17.4
297
1668
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
17.4
308
1751
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
1.9
17.4
248
1309
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
4.4
17.4
63
145
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
17.4
787
5660
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
9.0
17.3
36
40
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
17.3
369
2220
D64.9
ICD-10 Finland
Anaemia, unspecified
1.5
17.3
587
3978
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
18.6
17.3
26
14
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.2
17.2
169
761
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
17.1
316
1820
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
7.4
17.1
40
54
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
3.0
17.0
99
335
9440/3-C71.3
ICD-O-3
Glioblastoma, NOS, of parietal lobe
50.1
17.0
20
*
C71.39
ICD-10 Finland
Malignant tumor of parietal lobe other or unspecified histology
50.1
17.0
20
*
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
17.4
16.9
26
15
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
9.0
16.8
35
39
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
4.5
16.8
59
132
WZC30
NOMESCO Finland
Teaching
1.4
16.7
746
5347
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.5
16.7
131
529
C07AA05
ATC
propranolol; systemic
1.4
16.7
1094
8386
OAA67
SPAT
NA
0.5
16.7
131
2582
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.4
16.7
140
586
34531
ICD-8 Finland
Epilepsy, Patrialis (focalis) Jackson
+∞
16.7
16
*
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.7
16.7
359
2165
P72
ICPC
Schizophrenia
2.6
16.6
120
463
G05.1*B00.4
ICD-10 Finland
Herpesviral meningoencephalitis
15.0
16.6
27
18
G43.9
ICD-10 Finland
Migraine, unspecified
1.8
16.6
303
1742
AA1AA
NOMESCO Finland
Head X-ray examination
3.7
16.5
72
196
N06AB03
ATC
fluoxetine; oral
1.5
16.5
698
4947
RS122
NOMESCO Finland
NA
7.0
16.5
40
57
P85
ICPC
Mental retardation
8.2
16.4
36
44
G04.8
ICD-10 Finland
Other encephalitis, myelitis and encephalomyelitis
23.1
16.4
23
10
S06.9
ICD-10 Finland
Intracranial injury, unspecified
4.2
16.3
61
145
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.0
16.3
93
309
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
3.4
16.2
77
225
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
16.2
676
4782
ZX120
NOMESCO Finland
Intravenous
1.5
16.2
549
3715
C09AA05
ATC
ramipril; oral
1.3
16.1
1415
11328
R40.0
ICD-10 Finland
Somnolence
6.0
16.1
44
74
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
6.5
16.1
41
63
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
16.7
16.0
25
15
N05BA02
ATC
chlordiazepoxide; systemic
2.3
16.0
153
683
N06DX01
ATC
memantine; oral
1.7
16.0
334
1997
C02AC05
ATC
moxonidine; oral
1.8
16.0
262
1453
SPAT1251
SPAT
Organisation of medication
2.0
16.0
216
1119
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
21.0
15.9
23
11
XX3XW
NOMESCO Finland
NA
4.4
15.9
57
130
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
15.9
3478
30984
N04AA02
ATC
biperiden; systemic
2.5
15.9
127
520
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
8.5
15.9
34
40
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.9
15.8
223
1171
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
3.2
15.8
81
252
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
6.7
15.7
39
58
AA5FK
NOMESCO Finland
Functional assessment (fMRI) of brain
+∞
15.6
15
*
AAJ10
NOMESCO Finland
Lobectomy for epilepsy
+∞
15.6
15
*
3458X
ICD-9 Finland
Epilepsy, Other forms of epilepsy
+∞
15.6
15
*
B94.1
ICD-10 Finland
Sequelae of viral encephalitis
85.2
15.6
17
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
1.8
15.5
293
1699
S00.0
ICD-10 Finland
Superficial injury of scalp
2.4
15.5
131
552
R56
ICD-10 Finland
Convulsions, not elsewhere classified
22.0
15.5
22
10
M01AH05
ATC
etoricoxib; oral
0.8
15.5
2813
31813
9451/3-C71.1
ICD-O-3
Oligodendroglioma, anaplastic, NOS, of frontal lobe
160.3
15.5
16
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
15.4
1577
12877
S02.11
ICD-10 Finland
Fracture of base of skull, open
5.9
15.4
42
71
RT150
NOMESCO Finland
NA
5.3
15.3
46
87
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
5.8
15.3
43
75
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
3.4
15.3
72
210
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
15.2
1025
7886
OAB48
SPAT
NA
0.6
15.2
176
3106
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
28.6
15.2
20
7
3431A
ICD-9 Finland
Infantile cerebral palsy, Hemiplegic
28.6
15.2
20
7
N06AX21
ATC
duloxetine; oral
1.5
15.1
558
3849
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
13.0
15.1
26
20
H53.1
ICD-10 Finland
Subjective visual disturbances
1.7
15.1
339
2068
G43.3
ICD-10 Finland
Complicated migraine
2.8
15.1
97
349
S02.00
ICD-10 Finland
Fracture of the upper part of the head closed
5.6
15.0
43
77
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
3.5
15.0
70
203
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
2.8
14.9
98
359
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.4
14.9
126
531
XF404
NOMESCO Finland
Ambulatory ECG
1.5
14.9
533
3651
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.9
14.8
231
1260
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.4
14.8
128
546
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.0
14.8
179
890
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.1
14.7
79
254
E87.0
ICD-10 Finland
Hyperosmolality and hypernatraemia
5.3
14.7
44
83
K59.0
ICD-10 Finland
Constipation
1.7
14.6
324
1972
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.7
14.6
515
7165
WX725
NOMESCO Finland
Noninvasive ventilation
1.8
14.5
261
1494
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.6
14.5
358
2245
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.4
14.5
124
527
9401/3-C71.1
ICD-O-3
Astrocytoma, anaplastic, NOS, of frontal lobe
150.2
14.5
15
*
M05BA04
ATC
alendronic acid; oral
1.5
14.4
432
2843
F07.2
ICD-10 Finland
Postconcussional syndrome
10.8
14.4
27
25
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
36.1
14.4
18
5
Z29
ICPC
Social problem NOS
2.3
14.4
126
542
NB6AA
NOMESCO Finland
Humerus X-ray examination
2.4
14.4
117
485
Z71.8
ICD-10 Finland
Other specified counselling
1.3
14.4
1383
11189
A46
ICD-10 Finland
Erysipelas
1.4
14.3
788
5867
P99
ICPC
Psychological disorders other
2.1
14.3
157
750
J01CA08
ATC
pivmecillinam; oral
1.2
14.3
2122
18091
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
2.6
14.3
106
418
F06.7
ICD-10 Finland
Mild cognitive disorder
2.2
14.3
141
642
ZX095
NOMESCO Finland
Combined chemoradiotherapy
4.1
14.2
55
136
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
19.1
14.2
21
11
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
22.3
14.2
20
9
SPAT1167
SPAT
Insertion of urinary catheter
1.9
14.2
198
1041
F10.06
ICD-10 Finland
Alcohol-related acute intoxication with seizures
9.1
14.1
29
32
RS230
NOMESCO Finland
NA
4.5
14.1
49
109
WX402
NOMESCO Finland
General anaesthesia
1.3
14.1
938
7195
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.6
14.1
342
2136
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
42.5
14.1
17
*
N05CD02
ATC
nitrazepam; oral
2.4
14.1
117
489
N06AG02
ATC
moclobemide; oral
1.8
14.1
244
1382
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.4
14.1
120
508
XX1FW
NOMESCO Finland
Written report from MRI examination performed elsewhere
11.9
14.0
25
21
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
3.0
14.0
80
267
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
3.7
14.0
61
168
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
10.9
14.0
26
24
R2110
NOMESCO Finland
Giving the first information
1.6
13.9
374
2399
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
8.8
13.9
29
33
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
13.9
212
1150
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
3.2
13.9
73
232
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
1.8
13.9
238
1340
Y86
ICD-10 Finland
Sequelae of other accidents
5.1
13.9
43
85
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
6.8
13.9
34
50
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.7
13.8
281
1671
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
20.0
13.7
20
10
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
2.7
13.7
94
353
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
4.5
13.7
48
108
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
5.4
13.7
40
74
SPAT1260
SPAT
Consultation of another employee
1.3
13.7
1038
8123
P01
ICPC
Feeling anxious/nervous/tense
1.5
13.6
546
3831
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
13.6
1914
16202
RL140
NOMESCO Finland
NA
6.1
13.6
36
59
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
75.2
13.6
15
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
75.2
13.6
15
*
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
13.5
13
*
9401/3-C71.2
ICD-O-3
Astrocytoma, anaplastic, NOS, of temporal lobe
140.2
13.4
14
*
C71.82
ICD-10 Finland
Overall malignant tumor of the brain grade III glioma
140.2
13.4
14
*
N75
ICPC
Benign neoplasm nervous system
16.2
13.4
21
13
SPAT1153
SPAT
Removal of sutures
1.2
13.4
1851
15632
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
13.4
399
2624
RS121
NOMESCO Finland
NA
3.7
13.4
58
159
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
13.4
391
2560
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.0
13.4
164
821
S72.1
ICD-10 Finland
Pertrochanteric fracture
2.2
13.4
130
589
2151
FHL
Resection, big brain
25.8
13.3
18
7
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.0
13.3
159
787
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
4.2
13.3
50
121
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
4.0
13.2
52
131
G30.1
ICD-10 Finland
Alzheimer disease with late onset
1.7
13.2
295
1800
RT490
NOMESCO Finland
NA
10.4
13.2
25
24
A98
ICPC
Health maint/preventive medicine
0.8
13.2
6548
67887
S01.9
ICD-10 Finland
Open wound of head, part unspecified
2.4
13.2
112
476
G80.8
ICD-10 Finland
Other cerebral palsy
40.1
13.1
16
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
40.1
13.1
16
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
2.6
13.1
96
377
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.6
13.1
94
363
N06AA09
ATC
amitriptyline; systemic
1.5
13.1
528
3709
N05BE01
ATC
buspirone; oral
2.0
13.0
161
807
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.3
13.0
1281
10380
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.8
13.0
85
309
AAF15
NOMESCO Finland
Ventriculoatrial shunt
6.5
13.0
33
51
K08.3
ICD-10 Finland
Retained dental root
1.6
13.0
367
2381
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.9
13.0
190
1014
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
7.1
13.0
31
44
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
3.2
12.9
66
206
34300
ICD-8 Finland
Cerebral spastic infantile paralysis, Hemiplegia spastica
28.4
12.9
17
6
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.4
12.9
538
3801
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
4.2
12.9
48
115
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
7.3
12.9
30
41
AAD00
NOMESCO Finland
Evacuation of epidural haematoma
19.0
12.9
19
10
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
19.0
12.9
19
10
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
1.9
12.8
199
1087
C71.89
ICD-10 Finland
Overall malignant tumor of the brain other or unspecified histology
50.1
12.8
15
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.2
12.8
2438
21284
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.7
12.7
239
1390
F07.8
ICD-10 Finland
Other organic personality and behavioural disorders due to brain disease, damage and dysfunction
14.0
12.7
21
15
AA9CW
NOMESCO Finland
NA
7.2
12.7
30
42
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
12.6
752
5667
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
12.6
968
7583
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
12.2
12.6
22
18
F00.00*G30.0
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms
4.0
12.6
49
123
RS340
NOMESCO Finland
NA
6.4
12.6
32
50
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.2
12.5
126
579
34509
ICD-8 Finland
Epilepsy, Absentia epileptica NUD
+∞
12.5
12
*
XX9WW
NOMESCO Finland
NA
+∞
12.5
12
*
AA11X
NOMESCO Finland
NA
+∞
12.5
12
*
R13
ICD-10 Finland
Dysphagia
1.6
12.5
341
2197
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
12.5
2098
18070
P03
ICPC
Feeling depressed
1.5
12.5
483
3365
S00.1
ICD-10 Finland
Contusion of eyelid and periocular area
2.3
12.5
118
528
I63
ICD-10 Finland
Cerebral infarction
3.5
12.4
56
159
AAA40
NOMESCO Finland
Insertion of intracerebral electrodes
130.2
12.4
13
*
WX002
NOMESCO Finland
Sedation and analgesia
1.3
12.4
1104
8823
JDB10
NOMESCO Finland
Percutaneous gastrostomy
2.7
12.4
84
316
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.5
12.3
94
378
RS211
NOMESCO Finland
NA
4.2
12.3
46
111
J01DA01
ATC
[U] cefalexin; systemic
1.2
12.3
4020
36839
205
Kela drug reimbursment
Chronic hypertension
1.2
12.2
1621
13609
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.9
12.2
181
973
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
12.2
772
5879
G30.0
ICD-10 Finland
Alzheimer disease with early onset
3.3
12.2
59
178
SPAT1263
SPAT
Sampling
1.2
12.1
2647
23379
A12BA01
ATC
potassium chloride; oral
1.7
12.1
249
1489
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
3.2
12.1
62
195
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
1.9
12.0
172
911
F34.1
ICD-10 Finland
Dysthymia
1.9
12.0
182
984
R51
ICD-10 Finland
Headache
1.6
12.0
282
1749
C71.9
ICD-10 Finland
Malignant neoplasm: Brain, unspecified
26.7
12.0
16
6
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
26.7
12.0
16
6
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.6
12.0
85
329
C71.83
ICD-10 Finland
Overall malignant tumor of the brain grade IV glioma
21.3
12.0
17
8
F06.8
ICD-10 Finland
Other specified mental disorders due to brain damage and dysfunction and to physical disease
8.6
12.0
25
29
S70.0
ICD-10 Finland
Contusion of hip
1.8
11.9
198
1106
E86
ICD-10 Finland
Volume depletion
2.1
11.9
139
684
G93.8
ICD-10 Finland
Other specified disorders of brain
46.7
11.9
14
*
SPAT1104
SPAT
Monitoring of emergency patient
1.5
11.9
366
2427
K92.0
ICD-10 Finland
Haematemesis
2.0
11.9
143
712
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
4.2
11.8
44
106
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
2.7
11.7
78
290
9070A
ICD-9 Finland
Late effects of injuries to the nervous system, Late effect of intracranial injury without mention of skull fracture
10.5
11.7
22
21
J01FF01
ATC
clindamycin; systemic
1.2
11.7
1544
12941
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
4.3
11.7
42
98
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.1
11.7
137
673
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
7.3
11.7
27
37
43090
ICD-8 Finland
Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata
7.3
11.7
27
37
SPAT1101
SPAT
Orthostatic test
1.7
11.7
241
1441
N02AX02
ATC
tramadol; systemic, rectal
1.2
11.7
2494
21960
C71.93
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade IV glioma
65.0
11.6
13
*
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
65.0
11.6
13
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
7.7
11.6
26
34
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
4.3
11.6
42
99
9539/1-C70.0
ICD-O-3
Atypical meningioma of cerebral meninges
18.9
11.6
17
9
PA6AD
NOMESCO Finland
CT of neck arteries
2.8
11.6
74
270
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
1.9
11.6
160
840
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.5
11.5
356
2361
G30.8
ICD-10 Finland
Other Alzheimer disease
2.2
11.5
119
555
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
1.5
11.5
345
2275
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
11.5
378
2545
85190
ICD-8 Finland
Cerebral laceration and contusion, Late effect
10.0
11.5
22
22
S20.2
ICD-10 Finland
Contusion of thorax
1.6
11.5
263
1623
3457B
ICD-9 Finland
Epilepsy, Epilepsia partialis continua[EPILEPSIA PARTIALIS CONTINUA]
+∞
11.5
11
*
N03AD01
ATC
ethosuximide; oral
+∞
11.5
11
*
G40.5
ICD-10 Finland
Special epileptic syndromes
+∞
11.5
11
*
N03AF03
ATC
rufinamide; oral
+∞
11.5
11
*
SPAT1050
SPAT
Extensive neurological examination
2.0
11.4
136
675
G83.8
ICD-10 Finland
Other specified paralytic syndromes
13.6
11.4
19
14
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
2.0
11.4
151
781
N06DA02
ATC
donepezil; oral
1.6
11.4
280
1755
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
2.8
11.4
71
253
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.4
11.4
494
3520
F99
ICD-10 Finland
Mental disorder, not otherwise specified
2.2
11.4
111
506
N05AN01
ATC
lithium; oral
2.0
11.4
135
669
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.3
11.3
99
427
SPAT1262
SPAT
Handing over of treatment supplies
1.3
11.3
1034
8288
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.6
11.3
289
1833
4373A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured
8.9
11.2
23
26
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
8.9
11.2
23
26
Z43.0
ICD-10 Finland
Attention to tracheostomy
8.9
11.2
23
26
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.5
11.2
434
3027
A02BC01
ATC
omeprazole; systemic
1.2
11.2
1588
13414
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
1.7
11.2
214
1254
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
17.0
11.2
17
10
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
2.6
11.2
78
298
AA400
NOMESCO Finland
Electroconvulsive therapy
3.4
11.1
52
153
4311A
ICD-9 Finland
Intracerebral haemorrhage[HAEMORRHAGIA INTRACEREBRALIS HYPERTONIA NON INDICAT]
20.0
11.1
16
8
C07AB02
ATC
metoprolol; systemic
1.3
11.1
1174
9591
P16
ICPC
Acute alcohol abuse
2.4
11.1
91
380
S09.9
ICD-10 Finland
Unspecified injury of head
2.7
11.1
74
277
WF004
NOMESCO Finland
Palliative radiotherapy
2.2
11.0
108
491
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.4
11.0
560
4105
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.4
11.0
577
4254
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
11.0
987
7893
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
3.5
11.0
49
139
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
11.0
430
3002
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.0
11.0
141
721
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
2.8
11.0
67
238
5CM18
NOMESCO Finland
NA
4.8
10.9
35
73
96698
ICD-8 Finland
Other antiepileptics
43.3
10.9
13
*
JN4AD
NOMESCO Finland
Body CT examination
1.5
10.9
396
2727
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.6
10.8
77
299
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
10.8
243
1490
F06.30
ICD-10 Finland
Organic manic syndrome
11.9
10.8
19
16
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
10.8
2459
21742
WZA90
NOMESCO Finland
Other doctors statement
1.2
10.8
1325
11009
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.6
10.8
310
2026
R52.2
ICD-10 Finland
Other chronic pain
1.8
10.7
167
915
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
10.6
1075
8728
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.5
10.6
421
2947
S06.8
ICD-10 Finland
Other intracranial injuries
6.7
10.6
26
39
R62.0
ICD-10 Finland
Delayed milestone
3.0
10.6
58
192
G91.8
ICD-10 Finland
Other hydrocephalus
12.9
10.6
18
14
C71.91
ICD-10 Finland
Malignant tumor in unspecified location in the brain grade II glioma
60.1
10.6
12
*
AAK85
NOMESCO Finland
Replantation of previously excised part of skull cap
60.1
10.6
12
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.7
10.6
203
1188
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
2.9
10.6
62
214
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.2
10.5
105
484
F05.0
ICD-10 Finland
Delirium not superimposed on dementia, so described
5.3
10.5
31
59
S80.0
ICD-10 Finland
Contusion of knee
1.5
10.5
334
2231
G35
ICD-10 Finland
Multiple sclerosis
2.4
10.5
88
373
2961D
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]
4.5
10.5
36
81
R20.2
ICD-10 Finland
Paraesthesia of skin
1.5
10.4
333
2227
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.4
10.4
455
3249
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
3.0
10.4
57
189
43190
ICD-8 Finland
Cerebral haemorrhage, Intracerebralis, hypertonia non indicata
110.1
10.4
11
*
9382/3-C71.1
ICD-O-3
Oligoastrocytoma, NOS, of frontal lobe
+∞
10.4
10
*
C71.02
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles grade III glioma
+∞
10.4
10
*
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
10.4
10
*
S02.10
ICD-10 Finland
Fracture of base of skull, closed
4.3
10.3
37
87
B34.9
ICD-10 Finland
Viral infection, unspecified
1.8
10.3
162
894
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
10.6
10.2
19
18
N17
ICPC
Vertigo/dizziness
1.4
10.2
568
4230
SPAT1307
SPAT
Psychosocial counselling and guidance
1.5
10.2
329
2204
315
Kela drug reimbursment
Clopidogrel
2.5
10.2
77
310
U07
ICPC
Urine symptom/complaint other
1.6
10.2
291
1899
SPAT1304
SPAT
Counselling and guidance related to ageing
1.5
10.2
342
2313
N05CF02
ATC
zolpidem; oral
1.3
10.2
916
7322
F32.8
ICD-10 Finland
Other depressive episodes
2.4
10.2
84
355
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
4.4
10.2
35
79
F61.0
ICD-10 Finland
Mixed personality disorders
2.2
10.2
102
470
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
10.2
1620
13833
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
5.0
10.1
31
62
C10AA05
ATC
atorvastatin; oral
1.2
10.1
2109
18477
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
6.2
10.1
26
42
ZX090
NOMESCO Finland
Other technic of radiotherapy
1.9
10.0
144
770
N06AB05
ATC
paroxetine; oral
1.5
10.0
312
2079
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.0
10.0
123
621
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.7
10.0
346
4835
E000001
ATC
NA
1.2
10.0
1168
9644
D07AA02
ATC
hydrocortisone; topical
1.3
10.0
778
6105
G05.1
ICD-10 Finland
Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
40.1
10.0
12
*
C71
ICD-10 Finland
Malignant neoplasm of brain
40.1
10.0
12
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.4
9.9
496
3630
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
3.3
9.9
48
146
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
9.9
478
3475
RS142
NOMESCO Finland
NA
5.5
9.9
28
51
P76
ICPC
Depressive disorder
1.5
9.9
303
2010
CS494
NOMESCO Finland
Other visual field testing
2.0
9.9
119
593
RS313
NOMESCO Finland
NA
4.7
9.9
32
68
G04BD04
ATC
oxybutynin; oral, transdermal
1.5
9.9
287
1880
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.3
9.9
1038
8462
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
9.9
238
1488
G93.4
ICD-10 Finland
Encephalopathy, unspecified
4.9
9.9
31
64
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
0.6
9.8
118
2055
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
3.3
9.8
47
142
N87
ICPC
Parkinsonism
2.4
9.8
77
316
F40.2
ICD-10 Finland
Specific (isolated) phobias
3.1
9.8
51
164
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.0
9.8
127
652
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
20.0
9.8
14
7
R06.4
ICD-10 Finland
Hyperventilation
2.2
9.8
95
435
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.8
9.7
172
985
WF099
NOMESCO Finland
Other radiotherapy
3.6
9.7
42
117
F01.1
ICD-10 Finland
Multi-infarct dementia
9.5
9.7
19
20
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.2
9.7
1638
14057
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
6.5
9.7
24
37
N05AB01
ATC
dixyrazine; systemic
2.5
9.7
74
301
F70
ICD-10 Finland
Mild mental retardation
13.4
9.6
16
12
SPAT1210
SPAT
Application of cast or individual aid
1.6
9.6
224
1388
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
1.8
9.6
150
825
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.0
9.6
112
552
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
6.8
9.6
23
34
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.6
9.5
41
114
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
8.3
9.5
20
24
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
2.4
9.5
78
327
Z03
ICPC
Housing/neighbourhood problem
3.2
9.5
47
146
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.7
9.5
182
1067
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
15.0
9.5
15
10
F10.73
ICD-10 Finland
Residual or late-onset psychosis caused by alcohol dementia
7.1
9.5
22
31
R32
ICD-10 Finland
Unspecified urinary incontinence
1.9
9.5
139
749
J96.0
ICD-10 Finland
Acute respiratory failure
2.4
9.5
76
318
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
2.4
9.4
78
330
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
4.2
9.4
34
81
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
100.1
9.4
10
*
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
9.4
509
3776
AAM00
NOMESCO Finland
Puncture and evacuation of intracerebral abscess
30.0
9.4
12
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
1.9
9.4
126
657
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
17.5
9.4
14
8
2174
FHL
Delete a block
+∞
9.4
9
*
3456B
ICD-9 Finland
Epilepsy, Infantile spasms[EPILEPSIA MYOCLONICA CUM ASTASIA]
+∞
9.4
9
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
9.4
329
2252
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
9.3
2145
18927
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
2.6
9.3
64
245
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
21.7
9.3
13
6
J01MA12
ATC
levofloxacin; systemic
1.3
9.3
994
8117
SPAT1255
SPAT
Intravenous administration of medicine
1.5
9.3
350
2427
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
3.4
9.3
43
127
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.3
9.3
929
7525
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.4
9.3
74
307
N05AL01
ATC
sulpiride; systemic
2.2
9.3
86
385
OAA80
SPAT
NA
0.5
9.3
88
1632
Y09
ICD-10 Finland
Assault by unspecified means
3.9
9.3
36
92
I61.2
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, unspecified
9.5
9.2
18
19
SPAT1172
SPAT
Guidance concerning hydration
1.9
9.2
127
669
V03AA01
ATC
NA
2.1
9.2
95
445
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
4.0
9.2
35
88
SPAT1276
SPAT
Outlining of treatment with patient or their family members
1.9
9.2
133
715
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.6
9.1
64
249
R06.0
ICD-10 Finland
Dyspnoea
1.2
9.1
1368
11594
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
9.1
3153
28748
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
1.7
9.1
175
1030
AEA00
NOMESCO Finland
Replacement of impulse generator of stimulation device in the nervous system
3.9
9.1
35
89
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
9.1
66
262
F06.0
ICD-10 Finland
Organic hallucinosis
6.2
9.0
23
37
P70
ICPC
Dementia
2.1
9.0
102
499
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
8.3
9.0
19
23
N27
ICPC
Fear of neurological disease other
2.4
9.0
75
317
F21
ICPC
NA
3.0
9.0
50
169
80090
ICD-8 Finland
Fracture of vault of skull, Late effect
36.7
9.0
11
*
WW806
NOMESCO Finland
Transfer from treating institution to lower-Level care, accompanied by doctor
36.7
9.0
11
*
AAM10
NOMESCO Finland
Excision of intracerebral abscess
36.7
9.0
11
*
G93.6
ICD-10 Finland
Cerebral oedema
10.0
9.0
17
17
Z08
ICPC
Social welfare problem
2.4
9.0
72
300
NC2AA
NOMESCO Finland
Forearm X-ray examination
2.3
9.0
78
339
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
1.8
9.0
156
892
WW500
NOMESCO Finland
Blood transfusion
1.6
8.9
209
1298
UKC02
NOMESCO Finland
Cystoscopy
1.3
8.9
876
7081
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.8
8.9
144
803
E22.2
ICD-10 Finland
Syndrome of inappropriate secretion of antidiuretic hormone
7.4
8.9
20
27
Z60.8
ICD-10 Finland
Other problems related to social environment
4.6
8.9
29
63
L76
ICPC
Fracture: other
1.8
8.9
142
791
S06.1
ICD-10 Finland
Traumatic cerebral oedema
12.5
8.8
15
12
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
2.5
8.8
65
260
K02.1
ICD-10 Finland
Caries of dentine
1.2
8.8
3499
32207
N05AF05
ATC
zuclopenthixol; systemic
2.6
8.8
60
228
H50.1
ICD-10 Finland
Divergent concomitant strabismus
2.9
8.8
51
176
M05BX04
ATC
denosumab; parenteral
1.6
8.8
219
1387
9690A
ICD-9 Finland
Poisoning by psychotropic agents, Antidepressants
4.9
8.8
27
55
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
3.6
8.8
37
102
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
5.1
8.7
26
51
ZZA00
NOMESCO Finland
Split skin graft
1.7
8.7
159
920
XX2XW
NOMESCO Finland
Other teleradiological consultation
4.1
8.7
32
78
85100
ICD-8 Finland
Cerebral laceration and contusion, Without mention of open intracranial wound
5.3
8.7
25
47
OAB95
SPAT
NA
0.5
8.7
88
1604
S42.0
ICD-10 Finland
Fracture of clavicle
1.8
8.7
155
891
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.6
8.7
200
1239
D33.04
ICD-10 Finland
Temporal lobe
50.0
8.7
10
*
P74
ICPC
Anxiety disorder/anxiety state
1.7
8.7
176
1052
J01MA02
ATC
ciprofloxacin; systemic
1.2
8.7
2264
20169
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
1.9
8.6
126
677
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
4.8
8.6
27
56
S00.8
ICD-10 Finland
Superficial injury of other parts of head
2.1
8.6
89
419
C09AA02
ATC
enalapril; systemic
1.2
8.6
1091
9077
30010
ICD-8 Finland
Neuroses, Hysterical neurosis
7.6
8.6
19
25
NG1AA
SPAT
NA
0.5
8.6
53
1121
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.5
8.6
247
1619
Z72.2
ICD-10 Finland
Drug use
3.5
8.6
38
109
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.6
8.6
231
1488
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
6.1
8.6
22
36
A02BA02
ATC
ranitidine; systemic
1.2
8.6
1058
8781
5AB01
NOMESCO Finland
NA
5.8
8.6
23
40
J01CF02
ATC
cloxacillin; systemic
1.9
8.6
126
683
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.3
8.5
72
308
NFJ52
NOMESCO Finland
Internal fixation of fracture of upper femur with screws and sideplate
2.9
8.5
49
167
W06
ICD-10 Finland
Fall involving bed
2.9
8.5
50
175
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
2.1
8.5
95
462
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
1.8
8.5
135
750
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.7
8.5
178
1076
N05AC02
ATC
thioridazine; oral
2.0
8.5
102
512
A03FA02
ATC
cisapride; oral, rectal
1.4
8.5
399
2892
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.5
8.5
250
1650
9663A
ICD-9 Finland
Poisoning by anticonvulsants and anti-Parkinsonism drugs, Other and unspecified anticonvulsants[MYRKYTYS:KARBAMATSEPIINI]
20.0
8.5
12
6
S92.3
ICD-10 Finland
Fracture of metatarsal bone
1.7
8.4
176
1063
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
1.9
8.4
110
569
A10AE05
ATC
insulin detemir; parenteral
1.5
8.4
307
2119
2192
FHL
Cranioplasty
90.1
8.4
9
*
AA5JS
NOMESCO Finland
Extensive PET-MRI of brain metabolism
90.1
8.4
9
*
AA10D
NOMESCO Finland
NA
90.1
8.4
9
*
H47.1
ICD-10 Finland
Papilloedema, unspecified
3.5
8.4
37
106
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
8.4
749
5979
U28
ICPC
Limited function/disability (U)
2.6
8.4
58
224
I49.5
ICD-10 Finland
Sick sinus syndrome
1.6
8.4
195
1211
A10AA02
ATC
NA
1.6
8.4
187
1151
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.1
8.4
85
399
9382/3-C71.9
ICD-O-3
Oligoastrocytoma, NOS, of brain, NOS
+∞
8.3
8
*
9450/3-C71.3
ICD-O-3
Oligodendroglioma, NOS, of parietal lobe
+∞
8.3
8
*
199
Kela drug reimbursment
Rufinamide
+∞
8.3
8
*
A41.8
ICD-10 Finland
Other specified sepsis
2.1
8.3
87
413
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
3.0
8.3
46
156
A06
ICPC
Fainting/syncope
2.3
8.3
74
327
F93.89
ICD-10 Finland
Other childhood emotional disorders
2.7
8.3
53
195
RS220
NOMESCO Finland
NA
2.1
8.3
84
393
SPAT1310
SPAT
Counselling related to known health issue
1.2
8.3
1873
16475
AAA20
NOMESCO Finland
Insertion of intraventricular pressure monitoring device
5.5
8.3
23
42
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.0
8.2
100
505
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.2
8.2
78
353
X57
ICD-10 Finland
Unspecified privation
1.9
8.2
115
613
E0000UV
ATC
NA
1.2
8.2
2331
20885
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
3.5
8.2
36
103
3050A
ICD-9 Finland
Nondependent abuse of drugs, Alcohol abuse
2.7
8.2
54
204
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.4
8.2
348
2474
1287
NOMESCO Finland
NA
14.5
8.2
13
9
N06AA12
ATC
doxepin; systemic
1.5
8.2
263
1769
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.9
8.2
114
604
H52.2
ICD-10 Finland
Astigmatism
2.1
8.2
91
445
Z72.8
ICD-10 Finland
Other problems related to lifestyle
3.3
8.2
38
114
F20
ICD-10 Finland
Schizophrenia
3.3
8.2
38
114
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
6.5
8.2
20
31
SAA01
NOMESCO Finland
Simple examination of mouth
1.1
8.1
4465
41962
W17
ICD-10 Finland
Other fall from one level to another
1.5
8.1
235
1541
FPW96
NOMESCO Finland
Other operation for arhythmia or disturbance of impulse propagation
3.5
8.1
35
99
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
3.5
8.1
35
99
N03AA03
ATC
primidone; oral
5.7
8.1
22
39
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
2.8
8.1
49
176
SPAT1285
SPAT
Provision of consultation response
1.5
8.1
290
1997
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.3
8.1
620
4852
L16
ICPC
Ankle symptom/complaint
1.3
8.1
522
3984
PA2HT
NOMESCO Finland
Extensive embolisation of arterio-venous malformation of the brain
17.2
8.1
12
7
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
1.9
8.0
107
559
XX4AW
NOMESCO Finland
NA
3.4
8.0
36
105
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
22.0
8.0
11
5
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.7
8.0
225
3256
J45.9
ICD-10 Finland
Asthma, unspecified
1.2
8.0
960
7942
ZX114
NOMESCO Finland
Intramuscular
2.1
8.0
82
387
RT274
NOMESCO Finland
NA
5.5
8.0
22
40
A99
ICPC
Disease/condition unspecnature/site
1.4
7.9
410
3019
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
7.2
7.9
18
25
ZX070
NOMESCO Finland
Intensity modified radiotherapy
1.9
7.9
108
567
Z72.1
ICD-10 Finland
Alcohol use
2.3
7.9
69
303
TPX15
NOMESCO Finland
Removal of vascular injection port
3.6
7.9
34
96
280
Kela drug reimbursment
Clopidogrel
2.0
7.9
91
452
G43.2
ICD-10 Finland
Status migrainosus
4.9
7.9
24
49
R07.4
ICD-10 Finland
Chest pain, unspecified
1.2
7.9
1460
12618
Z11
ICPC
Compliance/being ill problem
2.9
7.8
45
154
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
6.1
7.8
20
33
H50.31
ICD-10 Finland
Intermittent exotropia
2.6
7.8
55
216
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
3.0
7.8
41
135
I63.6
ICD-10 Finland
Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
10.8
7.8
14
13
F10.6
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Amnesic syndrome
10.8
7.8
14
13
I95.9
ICD-10 Finland
Hypotension, unspecified
2.1
7.8
80
376
D07AB02
ATC
hydrocortisone butyrate; topical
1.2
7.7
1565
13621
F06.4
ICD-10 Finland
Organic anxiety disorder
6.9
7.7
18
26
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.4
7.7
407
3007
I21.99
ICD-10 Finland
Myocardial infarction (acute) UNS unspecified coronary artery status
1.7
7.7
139
802
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
4.4
7.7
26
59
F41.00
ICD-10 Finland
Moderate panic disorder
2.1
7.7
82
391
3199A
ICD-9 Finland
Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]
45.0
7.7
9
*
NBJ62
NOMESCO Finland
Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus
2.3
7.7
69
304
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.6
7.7
172
1061
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
1.7
7.7
137
792
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
2.7
7.7
50
188
C09CA06
ATC
candesartan; oral
1.2
7.7
1099
9263
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.6
7.6
208
1345
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.3
7.6
558
4340
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
1.7
7.6
156
939
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
2.9
7.6
44
152
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
2.2
7.6
75
349
G31.0
ICD-10 Finland
Circumscribed brain atrophy
3.8
7.6
30
79
K29
ICPC
Cardiovascular sympt/complt other
1.6
7.6
198
1267
Y94.0
ICD-10 Finland
Accident at home
2.0
7.6
97
499
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
8.0
7.6
16
20
4301A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]
25.0
7.6
10
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
1.9
7.5
109
587
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
1.8
7.5
117
647
N06AA06
ATC
trimipramine; systemic
1.8
7.5
117
647
SPAT1052
SPAT
Monitoring of level of consciousness and neurological symptoms
8.8
7.5
15
17
34400
ICD-8 Finland
Other cerebral paralysis, Hemiplegia NUD
8.8
7.5
15
17
2132
FHL
Ventricular operators sunt
8.8
7.5
15
17
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
2.5
7.5
56
226
R52.1
ICD-10 Finland
Chronic intractable pain
2.6
7.5
52
200
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
6.1
7.5
19
31
3016A
ICD-9 Finland
Personality disorders, Dependent personality disorder
10.0
7.5
14
14
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.4
7.5
62
263
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.7
7.5
139
814
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
1.9
7.5
103
547
M79.6
ICD-10 Finland
Pain in limb
1.2
7.5
1970
17520
H54.7
ICD-10 Finland
Unspecified visual loss
2.8
7.5
45
162
A10AE04
ATC
insulin glargine; parenteral
1.3
7.4
487
3727
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.0
7.4
90
457
C71.03
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade IV glioma
80.1
7.4
8
*
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.5
7.4
242
1637
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
1.5
7.4
227
1515
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.5
7.4
246
1668
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.3
7.4
632
5023
N07BC02
ATC
methadone; systemic
4.2
7.4
26
62
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.7
7.3
150
904
SPAT1380
SPAT
Postpartum check-up
0.7
7.3
160
2425
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.7
7.3
271
3740
F20.8
ICD-10 Finland
Other schizophrenia
3.7
7.3
30
82
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.5
7.3
238
1609
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.7
7.3
287
3922
AA5FM
NOMESCO Finland
Functional MRI examination of brain with 3 Tesla magnet
+∞
7.3
7
*
N03AX17
ATC
stiripentol; oral
+∞
7.3
7
*
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
7.3
7
*
Z28
ICPC
Limited function/disability (Z)
3.2
7.3
36
114
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
10.8
7.3
13
12
N06AX22
ATC
agomelatine; oral
1.9
7.3
103
552
XKC03
NOMESCO Finland
Water cystometry
1.7
7.3
144
860
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
4.9
7.3
22
45
S22.4
ICD-10 Finland
Multiple fractures of ribs
1.8
7.2
107
583
FPH96
NOMESCO Finland
Other removal of cardiac pacemaker or cardioverter-defibrillator
3.6
7.2
30
83
J69.8
ICD-10 Finland
Pneumonitis due to other solids and liquids
6.2
7.2
18
29
IGY02
NOMESCO Finland
Psychiatric monitoring contact
1.8
7.2
116
649
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
7.2
496
3825
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
5.8
7.2
19
33
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
5.8
7.2
19
33
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
5.8
7.2
19
33
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
7.2
376
2776
S01.3
ICD-10 Finland
Open wound of ear
2.3
7.2
60
257
R44.8
ICD-10 Finland
Other and unspecified symptoms and signs involving general sensations and perceptions
7.3
7.2
16
22
C08CA05
ATC
nifedipine; systemic
1.4
7.2
335
2427
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.4
7.2
292
2065
SPAT1227
SPAT
Substance abuse rehabilitation
2.8
7.1
43
155
P28
ICPC
Limited function/disability (P)
2.6
7.1
50
195
Y94.8
ICD-10 Finland
Other leisure activity accident
1.7
7.1
139
825
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.0
7.1
87
441
R44.0
ICD-10 Finland
Auditory hallucinations
3.6
7.1
30
84
R27.0
ICD-10 Finland
Ataxia, unspecified
3.6
7.1
30
84
R29.6
ICD-10 Finland
Tendency to fall, not elsewhere classified
3.8
7.1
28
74
AAK99
NOMESCO Finland
Other operation on skull or dura
20.0
7.1
10
5
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.1
2303
20795
N06AX05
ATC
trazodone; oral
1.8
7.1
121
692
AA6AD
NOMESCO Finland
Cranial bones CT examination
7.9
7.1
15
19
N31.0
ICD-10 Finland
Uninhibited neuropathic bladder, not elsewhere classified
4.2
7.1
25
60
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
7.1
687
5546
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
1.8
7.1
113
632
F07.0
ICD-10 Finland
Organic personality disorder
12.0
7.1
12
10
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
3.0
7.1
38
128
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.7
7.1
273
3739
M05BB03
ATC
alendronic acid and colecalciferol; oral
1.8
7.0
109
604
I68.0
ICD-10 Finland
Cerebral amyloid angiopathy
10.0
7.0
13
13
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.1
7.0
3202
29602
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
2.0
7.0
84
426
QAB00
NOMESCO Finland
Suture of skin of head or neck
2.1
7.0
75
364
Z50.1
ICD-10 Finland
Other physical therapy
1.4
7.0
278
1957
Z31.5
ICD-10 Finland
Genetic counselling
1.5
6.9
229
1552
9800A
ICD-9 Finland
Toxic effect of alcohol, Ethyl alcohol
4.9
6.9
21
43
AAG20
NOMESCO Finland
Stereotactic intracranial implantation of electrodes
4.9
6.9
21
43
NFB10
NOMESCO Finland
Primary partial prosthetic replacement of hip joint not using cement, other or unspecified
3.9
6.9
26
66
TPX10
NOMESCO Finland
Implantation of vascular injection port
1.7
6.9
137
817
RL130
NOMESCO Finland
NA
3.2
6.9
34
108
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
7.5
6.9
15
20
G81.0
ICD-10 Finland
Flaccid hemiplegia
7.5
6.9
15
20
F06.33
ICD-10 Finland
Organic mood syndrome
13.8
6.9
11
8
R52.9
ICD-10 Finland
Pain, unspecified
1.3
6.9
416
3151
AA1XD
NOMESCO Finland
Other special CT of head and brain
3.2
6.9
33
103
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
2.1
6.9
74
359
KMAK
NOMESCO Finland
NA
1.1
6.9
3059
28215
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
6.8
674
5450
A08
ICPC
Swelling
1.5
6.8
193
1263
A02BC03
ATC
lansoprazole; oral
1.2
6.8
1584
13933
W52
ICD-10 Finland
Crushed, pushed or stepped on by crowd or human stampede
2.0
6.8
83
423
Z43.5
ICD-10 Finland
Attention to cystostomy
3.1
6.8
34
109
RT190
NOMESCO Finland
NA
8.2
6.8
14
17
R3120
NOMESCO Finland
Training in mobility skills
8.2
6.8
14
17
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.4
6.8
290
2067
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
2.4
6.8
52
215
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
1.9
6.8
95
509
A79
ICPC
Malignancy NOS
2.2
6.8
64
294
T51.0
ICD-10 Finland
Toxic effect: Ethanol
3.2
6.8
33
104
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
0.8
6.8
766
9180
Q90.9
ICD-10 Finland
Down syndrome, unspecified
9.3
6.8
13
14
SPAT1243
SPAT
Psychiatric/psychological examination
1.7
6.8
137
822
S82.8
ICD-10 Finland
Fractures of other parts of lower leg
1.6
6.8
170
1082
9539/1-C70.9
ICD-O-3
Atypical meningioma of meninges, NOS
40.0
6.8
8
*
C08CA06
ATC
nimodipine; systemic
5.6
6.7
18
32
3430A
ICD-9 Finland
Infantile cerebral palsy, Diplegic
16.7
6.7
10
6
B00.4
ICD-10 Finland
Herpesviral encephalitis
16.7
6.7
10
6
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1.8
6.7
104
574
SPAT1293
SPAT
Other function in accordance with rehabilitation guidance nomenclature
3.0
6.7
35
116
K22.1
ICD-10 Finland
Ulcer of oesophagus
1.9
6.7
84
433
R41.2
ICD-10 Finland
Retrograde amnesia
7.1
6.7
15
21
G04BD08
ATC
solifenacin; oral
1.4
6.7
320
2333
T89
ICPC
Diabetes insulin dependent
1.5
6.7
197
1302
R5110
SPAT
NA
1.7
6.7
126
745
K89
ICPC
Transient cerebral ischaemia
2.4
6.7
54
230
A69
ICPC
General and Unspecified, Other reason for encounter NEC
1.7
6.6
129
766
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.1
6.6
67
314
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.4
6.6
254
1775
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.1
6.6
68
324
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
6.4
6.6
16
25
M05BA07
ATC
risedronic acid; oral
1.6
6.6
149
921
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.4
6.6
371
2777
M41.4
ICD-10 Finland
Neuromuscular scoliosis
7.8
6.6
14
18
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.4
6.6
343
2534
NG4AA
NOMESCO Finland
Lower leg X-ray examination
1.7
6.6
137
829
78259
ICD-8 Finland
Symptoms referable to cardiovascular and lymphatic system, Syncope (lipothymia) alia sive NUD
4.2
6.6
23
55
S82.4
ICD-10 Finland
Fracture of fibula alone
2.0
6.6
79
401
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.5
6.6
187
1228
W78
ICPC
Pregnancy
0.7
6.6
292
3916
J96.9
ICD-10 Finland
Respiratory failure, unspecified
2.9
6.6
38
133
AA1ED
NOMESCO Finland
Trauma CT of head and neck
3.0
6.6
35
118
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
2.0
6.6
74
366
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
1.4
6.6
253
1772
F80.2
ICD-10 Finland
Receptive language disorder
3.2
6.5
31
96
A07AA02
ATC
nystatin; oral
1.4
6.5
299
2163
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.6
6.5
145
895
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.8
6.5
509
6348
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
10.0
6.5
12
12
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.2
6.5
738
6066
A02BA04
ATC
nizatidine; systemic
1.3
6.5
383
2889
Z72.0
ICD-10 Finland
Tobacco use
1.7
6.5
114
659
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
6.5
66
310
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.4
6.5
359
2680
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
2.4
6.5
51
215
N05AB04
ATC
prochlorperazine; systemic, rectal
1.7
6.5
112
645
F39
ICD-10 Finland
Unspecified mood [affective] disorder
1.9
6.5
84
437
L17
ICPC
Foot/toe symptom/complaint
1.2
6.5
1358
11846
G93.1
ICD-10 Finland
Anoxic brain damage, not elsewhere classified
3.5
6.5
28
81
3AX01
NOMESCO Finland
NA
3.5
6.5
28
81
S62.6
ICD-10 Finland
Fracture of other finger
1.5
6.5
213
1447
C03DA01
ATC
spironolactone; oral
1.3
6.5
533
4215
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
1.7
6.5
136
829
S91.0
ICD-10 Finland
Open wound of ankle
2.4
6.5
50
209
F20.03
ICD-10 Finland
Paranoid schizophrenia periodically with gradual improvement
6.2
6.4
16
26
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.4
6.4
267
1894
S01.8
ICD-10 Finland
Open wound of other parts of head
2.1
6.4
68
325
R4120
SPAT
NA
4.5
6.4
21
47
G23.9
ICD-10 Finland
Degenerative disease of basal ganglia, unspecified
5.3
6.4
18
34
TAW99
NOMESCO Finland
Other minor neurosurgical procedure
3.0
6.4
34
114
SPAT1244
SPAT
Occupational therapy
2.2
6.4
58
260
AAF40
NOMESCO Finland
Shunt of cyst of brain to peritoneum
69.9
6.4
7
*
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
69.9
6.4
7
*
A10AA01
ATC
NA
1.6
6.4
137
837
NHJ10
NOMESCO Finland
Internal fixation of fracture of ankle using wire, rod, cerclage or pin
1.5
6.4
215
1465
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
1.5
6.4
182
1197
155
Kela drug reimbursment
Afatinib and gefitinib
7.4
6.4
14
19
AAA00
NOMESCO Finland
Exploratory craniotomy
14.3
6.4
10
7
L01XE13
ATC
[U] afatinib; oral
14.3
6.4
10
7
R35
ICD-10 Finland
Polyuria
1.4
6.4
309
2257
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.5
6.4
183
1203
E16.19
ICD-10 Finland
Other specified hypoglycaemia
3.5
6.4
27
77
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.3
6.4
423
3250
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
3.9
6.3
24
62
P48
ICPC
Psychological, Clarification/discussion RFE/demand
3.6
6.3
26
72
R00.1
ICD-10 Finland
Bradycardia, unspecified
1.6
6.3
161
1031
N05BB01
ATC
hydroxyzine; systemic
1.4
6.3
307
2245
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
2.0
6.3
70
344
N86
ICPC
Multiple sclerosis
2.8
6.3
38
138
5353A
ICD-9 Finland
Gastritis and duodenitis, Alcoholic gastritis
6.5
6.3
15
23
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
1.9
6.3
87
465
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.2
6.3
772
6401
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.4
6.3
276
1981
9532/0-C70.0
ICD-O-3
Fibrous meningioma of cerebral meninges
11.0
6.3
11
10
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
11.0
6.3
11
10
85200
ICD-8 Finland
Subarachnoid, subdural and extradural haemorrhage, following injury (without mention of cerebral laceration or contusion), Without mention of open intracranial wound
9.2
6.3
12
13
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
1.7
6.3
117
690
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.2
6.3
1136
9783
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
18.0
6.3
9
5
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
6.2
6
*
AA5MS
NOMESCO Finland
NA
+∞
6.2
6
*
43091
ICD-8 Finland
Subarachnoid haemorrhage, Postaneyrisma arteriovenosum, hypertonia non indicata
+∞
6.2
6
*
34511
ICD-8 Finland
Epilepsy, Motorica minoris
+∞
6.2
6
*
Q04.9
ICD-10 Finland
Congenital malformation of brain, unspecified
+∞
6.2
6
*
N03AB52
ATC
phenytoin, combinations; systemic
+∞
6.2
6
*
E87.5
ICD-10 Finland
Hyperkalaemia
1.9
6.2
83
439
Z73.6
ICD-10 Finland
Limitation of activities due to disability
2.5
6.2
45
181
R31
ICD-10 Finland
Unspecified haematuria
1.3
6.2
493
3881
Q03.9
ICD-10 Finland
Congenital hydrocephalus, unspecified
26.7
6.2
8
*
XA800
SPAT
NA
26.7
6.2
8
*
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
26.7
6.2
8
*
F10.05
ICD-10 Finland
Alcohol-related acute intoxication with coma
4.3
6.2
21
49
XX9XW
NOMESCO Finland
NA
2.4
6.2
46
189
2212
FHL
Hematoma removal, subdural
7.0
6.2
14
20
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
1.7
6.2
120
716
R06AE07
ATC
cetirizine; oral
1.1
6.2
2502
22889
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.4
6.2
265
1896
D18.0
ICD-10 Finland
Haemangioma, any site
1.8
6.2
105
600
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
6.2
156
998
E87.8
ICD-10 Finland
Other disorders of electrolyte and fluid balance, not elsewhere classified
4.5
6.1
20
45
A01
ICPC
Pain general/multiple sites
1.3
6.1
374
2834
F01.0
ICD-10 Finland
Vascular dementia of acute onset
5.7
6.1
16
28
P18
ICPC
Medication abuse
3.0
6.1
32
107
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
1.6
6.1
163
1053
I25.2
ICD-10 Finland
Old myocardial infarction
1.3
6.1
358
2698
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
1.8
6.1
103
590
S29
ICPC
Skin symptom/complaint other
1.2
6.1
868
7307
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
1.9
6.1
89
483
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
3.4
6.1
27
80
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
1.7
6.1
124
750
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
1.7
6.1
106
610
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
2.7
6.1
37
136
ZXF05
NOMESCO Finland
Interruption of procedure for other patient related reason
2.9
6.1
35
122
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
1.8
6.1
93
516
RT120
NOMESCO Finland
NA
3.8
6.1
23
60
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
8.6
6.0
12
14
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
2.7
6.0
38
143
GD1AA
SPAT
NA
0.7
6.0
161
2348
G03FA14
ATC
dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)
0.6
6.0
100
1605
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.5
6.0
173
1139
NF1AA
NOMESCO Finland
Hip X-ray examination
1.3
6.0
402
3089
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
2.5
6.0
44
179
F06.39
ICD-10 Finland
Organic mood syndrome UNS
10.0
6.0
11
11
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
10.0
6.0
11
11
F01.8
ICD-10 Finland
Other vascular dementia
10.0
6.0
11
11
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.5
6.0
223
1551
TJD20
NOMESCO Finland
Change of gastrostomy tube
3.0
6.0
31
103
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
4874
30710
2.33
316.64
7.5
6.3
mmol/l
1.2
1.2
31.86
4589
27843
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
439
581
7.90
312.85
1.8
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
743
1653
4.82
311.16
1.5
1.6
mg/l
531.5
512.3
0.43
715
1570
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
242
28
88.84
307.65
3.3
3.0
umol/l
42.7
38.6
0.32
221
20
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
704
64
119.55
307.65
3.2
2.1
umol/l
29.9
28.0
0.44
533
46
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
4411
20099
3.42
307.65
3.5
2.1
u/l
230.7
216.7
0.27
4265
18809
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2453
10666
2.81
307.65
2.4
2.3
s
28.9
30.0
12.19
2381
10341
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
1258
45
326.46
307.65
2.6
2.2
umol/l
54.5
48.4
0.63
1105
28
(3009466) Valproate [Moles/volume] in Serum or Plasma
1368
646
24.93
307.65
3.7
5.7
umol/l
367.4
364.7
0.17
1199
549
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
440
380
12.14
307.65
1.8
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
913
2263
4.39
307.65
2.3
2.4
ug/l
378.2
565.0
0.98
869
2126
(3003396) Base excess in Arterial blood by calculation
1858
7679
2.80
301.62
7.5
7.3
mmol/l
1.1
1.0
0.69
1434
5924
(3027801) Oxygen [Partial pressure] in Arterial blood
1860
7697
2.80
301.18
7.4
7.3
kpa
14.1
12.3
24.77
1772
7307
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1860
7700
2.80
300.93
7.5
7.3
kpa
5.0
5.1
1.46
1773
7313
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
675
1459
4.93
292.27
1.4
1.6
mmol/l
3.9
3.7
2.50
638
1365
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
208
89
23.91
290.69
2.2
2.0
umol/l
19.4
15.1
2.69
208
89
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
5140
33911
2.26
288.14
8.4
6.9
mmol/l
1.2
1.2
26.43
4491
28671
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
646
1457
4.71
265.18
1.6
1.7
e6/l
19.8
22.7
0.17
522
1110
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
645
1457
4.70
264.25
1.7
1.7
e6/l
1758.1
3448.2
0.29
544
1174
(3044290) Cell count panel - Cerebral spinal fluid
616
1341
4.87
263.97
1.6
1.7
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
123
17
73.35
228.02
1.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
5620
40510
2.09
224.51
7.2
4.8
mmol/l
6.6
6.7
2.74
5393
37742
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
327
485
6.96
209.87
1.5
1.2
mmol/l
2.2
2.0
1.46
303
450
(3023183) Ammonium ion [Moles/volume] in Plasma
567
1423
4.19
201.95
2.9
2.9
umol/l
31.7
34.4
1.67
490
1214
(3016502) Oxygen saturation in Arterial blood
1508
6917
2.43
189.46
8.3
7.7
%
96.0
95.6
1.31
1450
6640
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1416
6330
2.48
188.14
8.5
8.0
g/l
123.6
121.7
2.80
1375
6098
(3023368) Bacteria identified in Blood by Culture
3057
18717
1.97
182.48
4.7
4.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
255
341
7.67
179.50
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
250
332
7.72
177.03
1.2
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
241
320
7.71
170.66
1.7
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
4021
27433
1.86
168.91
9.4
9.3
inr
1.2
1.3
3.06
1155
7872
(3018418) pH of Serum or Plasma
3091
19810
1.87
154.68
4.1
4.1
ph
7.4
7.4
0.66
564
3781
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
3738
25467
1.82
152.93
4.8
3.6
ng/l
48.8
78.1
0.60
2851
17217
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1993
11095
2.03
151.17
4.0
3.8
mmol/l
0.8
0.8
0.98
1858
10348
(3016018) Differential panel - Cerebral spinal fluid
343
734
4.82
149.06
1.6
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1082
4733
2.47
148.44
6.6
8.5
mmol/l
24.4
24.8
3.92
1075
4700
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
892
3556
2.68
148.41
6.8
9.7
mmol/l
24.2
24.3
0.11
857
3295
(3008152) Bicarbonate [Moles/volume] in Arterial blood
992
4224
2.52
143.97
10.1
6.6
mmol/l
24.7
24.5
1.02
937
3928
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1955
11145
1.97
136.82
2.0
1.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
275
539
5.23
132.30
1.9
1.4
promille
0.8
1.4
7.63
222
421
(3019060) Gas panel - Arterial blood
999
4449
2.41
130.88
7.3
4.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
965
4232
2.44
130.81
7.8
9.3
%
0.7
0.7
6.47
958
4199
(3003181) Sodium [Moles/volume] in Urine
412
1124
3.80
129.91
1.5
1.5
mmol/l
71.0
64.5
1.90
341
912
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
963
4247
2.42
128.84
7.8
9.2
%
1.5
1.4
1.57
954
4218
(3036481) Cortisol [Moles/volume] in Serum or Plasma
1261
6298
2.17
125.40
2.4
2.2
nmol/l
371.2
370.4
0.04
1153
5802
(3014576) Chloride [Moles/volume] in Serum or Plasma
1572
8585
2.01
122.90
6.9
7.1
mmol/l
103.4
104.6
14.72
1533
8403
(3014111) Lactate [Moles/volume] in Serum or Plasma
1225
6103
2.17
122.39
6.2
7.3
mmol/l
1.4
1.4
1.59
1153
5839
(3024561) Albumin [Mass/volume] in Serum or Plasma
4025
29405
1.68
118.46
5.7
5.0
g/l
34.9
35.5
9.69
3767
27263
(3033658) Prothrombin time (PT) actual/Normal
2676
17590
1.75
115.43
4.7
4.2
%
89.4
88.7
0.81
2605
17151
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
157
201
7.93
114.60
1.2
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
294
693
4.35
113.09
1.7
2.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1419
7684
2.01
112.72
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1415
7665
2.01
112.26
1.9
1.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
618
2360
2.74
110.88
4.9
3.8
mmol/l
1.5
1.4
1.55
609
2318
(3026008) Bacteria identified in Urine by Culture
2945
20063
1.71
110.59
3.6
3.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
549
1999
2.86
107.74
5.2
4.0
mmol/l
3.9
3.9
0.99
521
1878
(3000991) Gas panel - Venous blood
1196
6213
2.07
106.05
6.9
8.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4528
35160
1.60
96.75
8.1
6.2
umol/l
9.9
11.9
23.30
4272
33275
(3020891) Body temperature
649
2731
2.49
95.17
6.0
4.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
836
4001
2.20
90.94
1.6
1.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1249
6931
1.94
90.83
4.2
4.6
kpa
5.9
5.8
1.83
1215
6719
(3002032) Base excess in Venous blood by calculation
1241
6912
1.93
89.13
4.2
4.6
mmol/l
2.0
1.8
1.05
1049
5569
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
134
192
7.07
88.61
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
3114
22488
1.60
87.77
4.2
3.3
mmol/l
2.3
2.4
9.89
2751
19623
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
130
184
7.15
86.93
1.2
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
131
188
7.06
86.50
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1077
5781
1.98
86.01
4.0
4.1
kpa
4.6
4.7
0.24
1046
5584
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
124
172
7.30
84.43
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
128
190
6.82
81.93
1.1
1.1
—
—
—
0
0
(3012544) pH of Venous blood
1249
7160
1.87
81.55
4.2
4.6
ph
7.4
7.4
—
6
47
(3036489) Thrombin time
599
2639
2.36
79.00
2.5
2.8
s
21.4
21.7
0.56
545
2320
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1516
9320
1.76
78.19
5.6
6.5
mmol/l
1.0
1.1
3.78
1404
8681
(3019309) Folate [Moles/volume] in Red Blood Cells
1929
12691
1.67
77.46
1.9
1.8
nmol/l
1193.9
1164.2
0.77
1528
9574
(3008295) Osmolality of Serum or Plasma
247
694
3.63
74.38
1.4
1.5
mosm/kgh2o
278.4
280.9
0.78
178
543
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
82
9
92.00
74.01
1.1
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
142
263
5.47
72.72
1.2
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
5421
45359
1.52
72.30
5.6
4.4
e6/l
2966.3
1776.5
0.56
99
633
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
1351
8226
1.76
71.46
10.1
7.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2948
21829
1.53
70.31
2.7
2.5
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
68
55
12.45
69.16
1.2
1.0
—
—
—
0
0
(3026782) Osmolality of Urine
2020
13830
1.60
67.73
2.9
2.8
mosm/kgh2o
546.6
553.2
0.65
1755
11788
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
225
638
3.59
66.83
1.1
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1033
5919
1.84
66.63
2.7
2.3
ug/l
6.0
7.4
2.01
891
5131
(3013650) Neutrophils [#/volume] in Blood by Automated count
4868
40203
1.48
66.42
11.6
9.1
e9/l
4.1
4.1
0.57
4279
34958
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
151
321
4.77
66.06
1.7
1.2
%
48.9
68.7
1.83
26
34
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
77
81
9.58
65.62
1.2
1.1
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1109
6522
1.80
65.62
6.5
7.9
mmol/l
7.9
9.7
16.86
1049
6219
(3006315) Basophils [#/volume] in Blood
4327
35087
1.46
63.74
7.0
6.1
e9/l
0.0
0.0
10.93
3756
30204
(3001604) Monocytes [#/volume] in Blood
4306
34927
1.46
63.06
7.0
6.0
e9/l
0.6
0.6
0.43
3739
30046
(3013115) Eosinophils [#/volume] in Blood
4441
36239
1.46
62.99
7.4
6.3
e9/l
0.2
0.2
13.23
3895
31709
(3019198) Lymphocytes [#/volume] in Blood
4410
35992
1.46
62.15
7.1
6.1
e9/l
1.8
1.9
2.08
3885
31591
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
711
3694
2.01
61.36
11.0
10.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
73
80
9.19
60.34
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1767
12046
1.59
59.21
3.2
3.0
mmol/l
2.4
2.5
6.62
1535
10495
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6019
52380
1.48
59.06
9.5
7.4
u/l
81.5
79.8
1.58
5699
49270
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
622
3134
2.06
58.36
3.6
3.2
%
0.7
0.7
1.48
604
2999
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
193
542
3.62
58.18
1.2
1.1
mg/l
37.8
40.9
0.54
166
447
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
187
525
3.62
56.40
1.1
1.1
mg/l
261.1
264.8
0.09
173
459
(3022217) INR in Platelet poor plasma by Coagulation assay
1382
8996
1.64
55.70
25.7
25.7
inr
1.3
1.4
0.62
158
1320
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
65
69
9.48
55.02
1.1
1.1
—
—
—
0
0
(4035726)
971
5776
1.77
54.67
1.4
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
2275
16685
1.49
53.62
2.5
2.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
752
4163
1.88
53.55
4.0
3.7
g/l
129.4
129.2
0.09
740
4062
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
828
4734
1.83
53.19
4.7
4.5
mmol/l
1.6
1.6
0.09
618
3467
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
123
265
4.69
53.00
1.2
1.1
ng/l
104.3
421.8
1.53
28
64
(42870588) Differential panel, method unspecified - Blood
3077
24004
1.44
52.25
6.8
6.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1739
24013
0.66
51.88
2.9
2.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
175
498
3.56
51.74
1.1
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
624
3286
1.97
51.57
3.8
3.6
mmol/l
25.2
25.2
0.12
608
3181
(3009343) pH of Capillary blood
842
4893
1.80
51.17
4.8
4.5
ph
7.4
7.4
1.42
90
547
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
547
2765
2.04
50.72
8.8
5.0
%
1.7
1.6
1.07
511
2580
(3051593) INR in Capillary blood by Coagulation assay
129
300
4.35
50.53
4.1
12.3
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
847
4953
1.79
50.36
4.8
4.5
kpa
5.2
5.1
2.90
788
4585
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
585
3045
1.99
49.96
4.4
4.2
%
51.2
48.6
1.82
580
3003
(3007930) Methemoglobin/Hemoglobin.total in Blood
542
2747
2.04
49.88
9.0
5.0
%
0.9
0.9
1.41
506
2568
(3016038) Potassium [Moles/volume] in Urine
162
455
3.61
48.87
1.4
1.4
mmol/l
34.0
35.4
0.30
139
402
(40761535) Cells panel - Urine sediment
916
5572
1.72
47.28
3.9
3.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
714
4043
1.83
47.12
1.7
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2866
22382
1.42
47.10
4.2
3.3
u/l
32.3
34.9
0.81
2704
21204
(3039000) Anion gap in Blood
346
1500
2.36
47.05
12.0
6.7
mmol/l
11.0
11.3
0.88
312
1338
(3018572) Chloride [Moles/volume] in Blood
346
1501
2.36
46.97
12.0
6.7
mmol/l
104.6
105.1
0.81
312
1339
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
83
141
5.93
46.64
1.1
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
2022
14838
1.47
46.35
5.0
4.0
kg/l
1.0
1.0
0.04
280
2266
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
216
751
2.92
45.91
1.6
1.7
—
—
—
0
0
(4027681)
150
418
3.63
45.80
1.3
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2748
21401
1.41
45.49
3.1
2.6
u/l
56.7
58.0
0.52
2550
19776
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
85
155
5.53
44.35
1.1
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
33
16
20.69
43.43
1.1
1.0
—
—
—
0
0
(4198724)
133
356
3.78
43.09
1.7
3.1
—
—
—
0
0
(3010421) pH of Blood
387
1826
2.17
42.95
4.2
4.4
ph
7.4
7.4
3.44
329
1542
(3022096) Basophils/100 leukocytes in Blood
3844
31907
1.37
42.39
7.1
6.3
%
0.6
0.7
4.59
3611
29767
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1820
13281
1.47
42.37
4.5
3.8
ng/l
230.4
519.6
2.85
1413
10301
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
61
84
7.30
41.85
1.5
1.1
%
47.4
56.6
0.54
29
35
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
3870
32226
1.36
41.49
4.5
4.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
676
3911
1.79
41.39
4.2
5.2
mmol/l
24.1
24.0
0.41
622
3558
(40758558) Short blood count panel - Blood
2314
17728
1.42
41.19
8.3
7.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
3931
32880
1.36
40.63
7.1
6.3
%
2.6
2.9
10.29
3685
30625
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
77
140
5.54
40.33
1.1
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
3946
33065
1.35
40.12
7.5
6.6
%
9.0
8.6
9.10
3704
30943
(3047181) Lactate [Moles/volume] in Blood
425
2142
2.03
39.61
11.1
5.7
mmol/l
1.4
1.3
1.23
377
1878
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
1240
8528
1.53
38.16
2.3
1.7
%
1.7
1.4
18.95
1100
7492
(3030467) Casts [#/volume] in Urine by Automated count
2483
19487
1.38
37.66
3.6
3.3
e6/l
0.4
0.4
0.04
1988
14681
(3012501) Base excess in Blood by calculation
335
1573
2.17
37.62
4.3
4.5
mmol/l
2.3
2.5
0.84
240
1042
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
38
32
11.92
37.62
1.0
1.1
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
1966
14831
1.42
37.61
2.9
2.7
e6/l
5.8
5.3
0.77
1782
12973
(3013290) Carbon dioxide [Partial pressure] in Blood
335
1574
2.17
37.56
4.3
4.5
kpa
5.1
5.0
1.75
329
1541
(3027315) Oxygen [Partial pressure] in Blood
336
1583
2.17
37.42
4.3
4.5
kpa
8.6
8.6
0.16
330
1549
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
147
462
3.22
37.25
1.1
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
259
1097
2.40
37.13
2.3
1.9
mmol/l
2.3
1.7
6.91
253
1074
(3002582) Erythrocytes [#/volume] in Urine
2669
21263
1.37
36.66
3.7
3.4
e6/l
60.1
93.6
1.46
2163
16357
(3002030) Lymphocytes/100 leukocytes in Blood
4014
34045
1.33
36.18
7.3
6.3
%
26.8
28.2
11.64
3772
31692
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
55
81
6.82
35.54
1.1
1.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
3952
33525
1.33
35.21
7.0
6.1
%
57.8
57.0
3.97
3722
31340
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
449
2409
1.91
34.90
3.6
4.0
u/ml
0.4
0.3
1.01
301
1371
(36304419) Bacteria [Presence] in Urine
2407
18987
1.37
34.80
3.5
3.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
287
1307
2.24
34.77
3.1
3.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
2305
18125
1.37
33.80
4.9
4.0
estimate
0.0
0.0
2.60
684
6112
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
410
2169
1.93
33.23
3.1
3.4
g/l
3.4
3.5
0.50
392
2066
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
179
670
2.71
33.22
1.6
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
2012
15523
1.38
33.07
1.7
1.5
nmol/l
18.3
20.1
7.22
1788
13339
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
488
2735
1.83
33.06
2.5
1.9
ug/l
3.0
2.4
0.41
407
2406
(3011397) Hemoglobin [Presence] in Urine by Test strip
2063
15986
1.38
33.00
4.4
3.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
779
4990
1.62
32.41
1.9
1.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
3007
24738
1.33
32.34
4.3
3.8
e6/l
100.2
93.4
0.10
2299
17549
(3019550) Sodium [Moles/volume] in Serum or Plasma
7515
70611
1.47
31.82
26.8
16.2
mmol/l
138.4
139.7
191.02
7394
68736
(1616796) Gas panel - Central venous blood
323
1608
2.05
31.13
3.6
3.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
5154
45819
1.30
30.75
4.4
3.1
u/l
66.1
47.1
26.47
4865
42726
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
464
2621
1.81
30.62
2.0
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
382
2031
1.92
30.50
1.3
1.3
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
83
204
4.10
30.37
1.4
1.2
%
20.3
29.9
0.48
21
21
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2244
17842
1.35
29.94
2.3
2.3
mg/l
3.0
2.9
0.09
1891
15299
(3037467) Urinalysis macro (dipstick) panel - Urine
5323
47626
1.30
29.74
5.1
4.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
299
1487
2.05
28.91
2.6
2.5
%
16.9
16.4
1.29
140
786
(3007853) Bacteria identified in Skin by Aerobe culture
1160
8358
1.45
27.63
1.9
1.8
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
203
881
2.33
27.62
2.2
1.9
%
89.2
89.6
0.55
197
871
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
53
98
5.43
27.33
1.1
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
7494
70831
1.41
26.44
26.2
16.4
mmol/l
4.0
4.0
0.35
7356
68816
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
119
406
2.96
26.32
1.0
1.0
ng/l
284.6
322.9
0.83
85
276
(3028626) Oxygen [Partial pressure] in Capillary blood
395
2226
1.81
26.26
5.4
5.0
kpa
8.8
8.7
0.69
380
2078
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
533
3271
1.67
26.17
5.5
4.9
mmol/l
24.8
24.7
0.38
500
3036
(3015235) Bicarbonate [Moles/volume] in Capillary blood
340
1834
1.89
25.99
3.5
3.4
mmol/l
24.3
24.7
1.08
314
1590
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
52
100
5.22
25.70
1.1
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
108
355
3.07
25.51
1.1
1.1
u/l
1.0
1.1
0.23
50
168
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
118
408
2.92
25.50
1.0
1.0
ng/l
750.6
735.4
0.12
82
268
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
353
6139
0.56
25.47
1.7
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
6200
66425
0.77
25.46
4.3
4.2
mmol/l
1.5
1.4
2.55
5719
61353
(3035350) Ketones [Presence] in Urine by Test strip
3873
33661
1.27
25.41
4.4
3.6
estimate
0.0
0.0
1.34
706
6238
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
118
410
2.90
25.28
1.0
1.0
ng/l
38.3
43.9
0.87
82
276
(3019225) pH of Specimen
932
6545
1.47
25.24
4.6
4.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
3228
27461
1.28
25.15
2.1
2.0
pmol/l
93.8
95.1
0.82
1789
14561
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
1090
7891
1.44
25.15
4.5
4.3
u/l
252.0
243.2
0.50
1023
7459
(3022313) Gas panel - Capillary blood
577
3661
1.62
24.81
5.1
4.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1549
11927
1.36
24.80
3.1
2.9
e6/l
1.2
1.1
0.37
910
6856
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
29
31
9.38
24.38
1.2
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
365
2077
1.79
23.50
3.7
3.2
%
186.3
187.8
0.12
347
1983
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
6278
66931
0.78
22.91
4.4
4.3
mmol/l
4.6
4.6
2.93
5823
62153
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
36
54
6.69
22.90
1.2
1.1
%
11.8
19.8
—
6
15
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1875
15009
1.32
22.83
2.1
1.9
mg/l
1.2
1.2
0.03
1440
11408
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
29
34
8.55
22.74
1.8
1.2
%
30.9
40.3
0.41
23
20
(3052851) Hemolysis interference index of Serum or Plasma
365
2100
1.77
22.65
3.7
3.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
99
335
2.98
22.29
3.0
3.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
3880
34072
1.25
22.13
4.5
3.6
estimate
0.0
0.0
2.44
696
6191
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
34
50
6.82
22.03
1.1
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
6416
68130
0.78
21.92
4.8
4.7
mmol/l
2.7
2.7
8.98
5925
62883
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
286
1549
1.87
21.63
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
286
1549
1.87
21.63
1.4
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
194
925
2.12
21.08
6.3
6.9
mg/l
10.6
11.6
2.54
169
847
(3021601) Nitrite [Presence] in Urine by Test strip
3829
33710
1.24
20.89
5.8
4.9
estimate
0.0
0.0
0.80
717
6378
(21494755) Public health laboratory ask at order entry panel
425
6686
0.62
20.59
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1430
11191
1.33
20.11
3.3
3.0
e6/l
3.4
2.3
2.96
797
6162
(3042936) Bacteria identified in Isolate by Culture
1269
9757
1.35
20.10
2.3
2.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
383
2310
1.69
20.08
2.9
3.4
%
95.3
91.3
2.47
358
2173
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
87
291
3.01
20.03
2.0
2.4
umol/l
152.3
158.6
0.06
42
160
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
7339
69739
1.33
19.99
22.6
14.1
mg/l
24.3
24.2
0.13
6370
55045
(3035637) Corticotropin [Mass/volume] in Plasma
197
966
2.06
19.90
1.6
1.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
48
108
4.46
19.79
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
455
2880
1.61
19.74
2.1
1.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
223
4121
0.53
19.70
1.4
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
147
645
2.30
19.62
2.6
2.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1780
14404
1.30
19.57
1.7
1.7
pmol/l
35393340.9
28544438.6
0.19
1489
11985
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
3004
25987
1.24
18.58
4.8
3.8
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
747
5324
1.44
18.52
2.5
2.7
g/l
10.1
10.4
0.84
682
4882
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
36
67
5.39
18.49
1.1
1.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
2281
19174
1.26
18.18
3.2
3.2
ng/l
1557.7
1548.8
0.03
1983
16415
(3027945) Reticulocytes/100 erythrocytes in Blood
1063
8077
1.36
18.06
3.0
2.7
%
1.8
1.7
2.38
936
7161
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
5651
52364
1.22
17.18
4.3
3.9
pmol/l
14.3
14.8
33.05
5179
47591
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
87
319
2.74
17.01
2.5
2.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
379
2386
1.61
16.83
2.8
2.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
814
5994
1.39
16.73
2.8
2.7
e9/l
71.0
69.0
0.81
603
4490
(3021589) Normoblasts [#/volume] in Blood
3504
31045
1.21
16.60
11.2
9.7
e9/l
0.0
0.0
0.45
2854
25235
(3020630) Protein [Mass/volume] in Serum or Plasma
764
5583
1.40
16.42
2.3
2.5
g/l
65.8
66.3
0.88
689
5070
(3021901) Oxygen saturation in Capillary blood
236
1317
1.81
16.31
2.8
2.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
76
266
2.87
16.22
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
6055
64146
0.82
16.10
4.0
3.8
mmol/l
1.3
1.3
0.19
5582
58863
(3028679) Herpes simplex virus Ab [Presence] in Serum
92
362
2.56
15.68
1.2
1.2
—
—
—
0
0
(4034850)
343
2148
1.62
15.58
11.8
9.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
428
2844
1.53
15.05
2.7
2.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
84
324
2.61
14.93
1.8
2.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
255
1501
1.72
14.71
4.0
3.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
856
6496
1.35
14.53
2.5
2.4
g/l
0.2
0.2
0.34
788
6036
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
321
2027
1.61
14.12
1.7
1.7
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
79
305
2.60
14.04
2.6
2.2
mmol/l
10.1
9.3
0.64
65
230
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
186
1012
1.86
14.01
1.2
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
157
810
1.95
13.89
10.5
7.2
mmol/l
7.2
7.3
0.05
132
674
(3000764) Benzodiazepines [Presence] in Urine
446
3043
1.49
13.84
2.6
2.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
35
82
4.28
13.79
1.8
1.9
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
586
4214
1.42
13.78
1.3
1.3
au/ml
31.4
51.9
2.07
17
175
(3028300) Cannabinoids [Presence] in Urine
448
3067
1.49
13.67
2.6
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
447
3062
1.48
13.60
2.6
2.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
80
317
2.54
13.50
1.7
2.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
630
4608
1.40
13.43
2.3
2.4
au/ml
37.5
22.7
1.54
17
260
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
48
144
3.35
13.35
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
434
3004
1.47
12.55
2.3
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
315
2042
1.56
12.43
3.7
3.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
449
3159
1.44
11.93
1.9
1.7
g/l
1.5
1.5
0.44
361
2714
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
34
89
3.83
11.60
1.1
2.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
216
1301
1.68
11.53
1.6
1.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
95
439
2.18
11.39
2.8
3.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
605
4532
1.36
11.14
2.0
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
881
6975
1.29
10.99
4.2
3.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
3103
27903
1.17
10.97
2.3
2.3
nmol/l
73.6
76.4
6.51
2763
25178
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
179
1042
1.73
10.86
1.4
1.3
u/ml
3.8
4.2
0.21
84
465
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
14
17
8.24
10.60
1.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
43
141
3.06
10.43
1.6
1.5
—
—
—
0
0
(44790049)
147
822
1.80
10.26
1.5
1.6
—
—
—
0
0
(44790048)
147
822
1.80
10.26
1.5
1.6
—
—
—
0
0
(44806118)
147
822
1.80
10.26
1.5
1.6
—
—
—
0
0
(44790047)
147
822
1.80
10.26
1.5
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
714
5547
1.31
10.25
4.1
4.0
mmol/l
1.2
1.2
5.36
664
4836
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
11
10
11.01
10.15
1.3
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1123
13522
0.81
10.10
2.7
3.0
ug/l
0.8
0.8
0.11
782
8925
(3011985) Renin [Units/volume] in Plasma
155
886
1.76
10.05
1.6
1.5
mu/l
60.4
69.8
0.26
143
779
(3008757) Leukocyte morphology finding [Identifier] in Blood
137
762
1.81
9.75
3.4
4.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
62
256
2.43
9.71
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
245
1594
1.55
9.61
1.5
1.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
81
379
2.15
9.49
2.2
2.5
umol/l
45.0
42.6
0.04
11
41
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
256
1687
1.53
9.48
1.7
1.7
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
26
66
3.95
9.29
1.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
221
3364
0.65
9.21
1.7
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
250
1652
1.53
9.15
1.7
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
535
4055
1.34
9.14
2.8
3.3
pmol/l
4.3
4.5
4.81
479
3593
(3049233) Organic acids panel - Urine
16
27
5.93
9.11
1.4
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
71
321
2.22
9.07
1.1
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
57
235
2.43
8.99
1.5
1.5
pmol/l
13.0
15.6
2.11
50
198
(3022948) Iron [Moles/volume] in Serum or Plasma
1311
11097
1.21
8.97
2.6
2.6
umol/l
12.8
13.0
0.66
1196
10286
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1505
17416
0.84
8.89
1.6
1.6
mmol/l
1.4
1.4
0.09
1297
14717
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
129
727
1.79
8.84
2.7
3.0
nmol/l
20.3
20.1
0.08
118
700
(3011412) CD3 cells [#/volume] in Blood
132
753
1.76
8.69
2.5
2.6
e9/l
1.0
1.2
1.55
80
469
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
796
6409
1.27
8.65
2.6
2.5
u/l
35.8
44.1
0.54
675
5485
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
106
566
1.88
8.64
1.6
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
106
566
1.88
8.64
1.6
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
106
566
1.88
8.64
1.6
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
321
2268
1.43
8.43
2.5
2.6
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
26
71
3.67
8.42
1.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
38
132
2.89
8.40
1.8
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
68
314
2.17
8.29
1.2
1.1
miu/ml
1645.1
1517.1
0.36
68
314
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
34
112
3.04
8.25
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1755
15367
1.18
8.16
5.5
4.5
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1212
10281
1.21
8.06
2.6
2.5
g/l
2.3
2.3
1.00
1116
9507
(3017181) Myelocytes/100 leukocytes in Blood
726
5832
1.27
8.04
4.2
4.3
%
1.1
0.9
1.51
253
1647
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
141
840
1.69
7.99
1.2
1.4
pmol/l
291.9
329.2
0.34
117
629
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
170
1066
1.61
7.89
1.4
1.3
u/ml
4.5
3.8
0.21
63
349
(3013707) Erythrocyte sedimentation rate by Westergren method
5350
50750
1.14
7.82
4.1
4.0
mm/h
12.5
11.9
2.12
4993
46950
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
101
550
1.85
7.79
2.6
2.7
e6/l
474.3
507.7
0.32
83
452
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
98
531
1.85
7.69
2.6
2.8
e9/l
0.2
0.2
0.21
83
448
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
184
1185
1.56
7.64
1.5
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
239
1630
1.48
7.59
2.2
2.2
g/l
132.4
129.8
0.95
196
1178
(3023419) Bacteria identified in Sputum by Culture
136
815
1.68
7.56
2.6
2.7
—
—
—
0
0
(3013512) EKG study
2140
19136
1.16
7.51
4.4
3.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
338
2463
1.39
7.48
1.8
1.6
mu/l
359.4
296.9
2.33
307
2238
(3004809) Band form neutrophils/100 leukocytes in Blood
179
1153
1.56
7.44
3.0
3.6
%
1.6
1.5
0.09
143
878
(3051611) Lipemic interference index of Serum or Plasma
122
718
1.71
7.27
3.1
3.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
6209
64415
0.87
7.24
24.2
15.1
%
38.8
39.9
18.22
4154
47112
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
269
1896
1.43
7.21
1.2
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
147
912
1.62
7.16
1.4
1.4
u/l
21.9
25.3
0.75
122
766
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
78
403
1.94
7.10
2.8
2.5
%
43.7
38.3
1.34
37
141
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
47
200
2.36
7.00
4.1
2.7
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
47
200
2.36
7.00
4.1
2.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
27
86
3.15
6.96
1.5
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
7423
72262
1.18
6.93
20.8
13.2
—
—
—
0
0
(3019977) pH of Arterial blood
74
380
1.95
6.87
3.3
2.7
ph
7.4
7.4
0.39
20
135
(3030981) Hyaline casts [#/volume] in Urine by Automated count
467
3621
1.31
6.86
3.0
2.8
e6/l
0.3
0.3
0.29
457
3535
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
284
2045
1.40
6.78
2.3
1.6
g/l
0.2
0.2
0.62
270
1935
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
292
2113
1.39
6.77
2.2
1.6
g/l
1.2
1.2
0.06
277
2001
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1120
9585
1.19
6.72
2.7
2.6
%
22.5
22.6
0.04
923
8201
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
65
322
2.03
6.68
4.7
1.9
%
164.0
143.2
1.20
60
308
(3042517) Benzodiazepines panel - Urine
25
78
3.21
6.68
3.4
2.7
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
23
68
3.39
6.67
1.5
1.7
—
—
—
0
0
(3044889) 12 lead EKG panel
4957
47021
1.13
6.67
4.1
3.7
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
37
144
2.58
6.67
1.1
1.2
%
75.3
70.7
—
7
44
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
218
1502
1.46
6.63
1.3
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
945
7973
1.21
6.62
3.2
3.1
umol/l
6.5
8.2
4.12
789
6911
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
217
3092
0.69
6.54
1.4
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
341
2563
1.34
6.26
2.5
2.3
u/l
6050.8
5468.4
0.11
93
1000
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
36
143
2.52
6.25
1.0
1.2
%
63.6
77.3
—
7
44
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
182
1226
1.49
6.22
1.8
1.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
135
851
1.60
6.22
3.6
2.3
mmol/l
104.2
105.6
2.34
135
840
(3032352) Blasts [#/volume] in Cerebral spinal fluid
26
87
2.99
6.21
2.0
4.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
135
853
1.59
6.17
3.6
2.3
mmol/l
4.0
4.1
0.54
135
842
(3033705) Calcium.ionized [Moles/volume] in Venous blood
132
831
1.60
6.13
3.7
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
109
654
1.67
6.12
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
666
5473
1.23
6.07
3.3
2.6
ml/min/173m2
71.5
66.3
2.15
282
2184
(3037756) Immunofixation for Serum or Plasma
199
1378
1.45
5.94
1.3
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
33
129
2.56
5.93
1.3
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
647
5314
1.23
5.93
4.0
4.1
%
0.7
0.6
0.33
167
1207
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
71
380
1.87
5.89
1.3
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
209
1465
1.44
5.86
5.4
6.2
iu/ml
356.9
2343.8
0.99
34
217
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
102
609
1.68
5.85
2.4
2.4
%
15.2
12.6
0.87
57
319
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
99
589
1.69
5.76
2.5
2.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
14
32
4.38
5.75
2.3
5.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
168
1133
1.49
5.75
3.1
3.9
u/ml
383.1
1737.4
—
10
76
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
85
486
1.76
5.70
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
591
7183
0.81
5.69
1.4
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
75
1308
0.57
5.66
1.5
1.6
—
—
—
0
0
(4268621)
116
723
1.61
5.65
2.5
2.3
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
103
623
1.66
5.64
2.4
2.4
%
74.6
71.2
1.67
98
596
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
6494
62865
1.13
5.55
5.2
4.6
mu/l
2.0
2.1
0.13
6028
57608
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
5988
61929
0.89
5.45
5.7
5.6
mmol/mol
39.3
39.7
2.85
5558
57382
(3009445) Proteinase 3 Ab [Units/volume] in Serum
381
2970
1.30
5.45
1.5
1.6
u/ml
32.4
14.5
—
9
90
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
703
5885
1.21
5.36
3.0
3.1
ng/l
182.2
214.3
1.63
637
5334
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
51
252
2.03
5.36
4.7
1.9
%
180.5
169.7
0.33
51
239
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
46
220
2.10
5.27
1.0
1.1
%
77.3
88.2
0.62
11
113
(3014148) Varicella zoster virus Ab [Titer] in Serum
140
927
1.52
5.27
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
665
5548
1.21
5.25
4.4
4.3
%
0.1
0.1
0.01
230
1538
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
22
74
2.98
5.24
2.2
2.1
—
—
—
0
0
(3012787) Ethosuximide [Moles/volume] in Serum or Plasma
5
0
+∞
5.21
2.6
0.0
umol/l
288.0
—
—
5
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
70
389
1.81
5.20
12.7
11.9
mmol/l
0.6
0.6
0.07
64
359
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
35
151
2.32
5.15
2.6
2.3
mmol/l
1.5
1.7
0.12
22
110
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
148
998
1.49
5.12
1.2
1.1
%
118.7
114.7
0.80
129
901
(3028026) IgM [Mass/volume] in Serum or Plasma
510
4154
1.24
5.08
1.8
1.9
g/l
1.2
1.3
1.11
465
3803
(40768800) Prostate Pathology biopsy report
89
1427
0.62
4.87
1.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
109
697
1.57
4.83
2.7
3.6
%
59.1
57.9
0.18
73
435
(3037121) Protein [Mass/volume] in Urine
320
2480
1.30
4.82
3.5
3.5
g/l
0.2
0.3
2.99
172
1158
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
44
215
2.05
4.80
1.0
1.2
%
70.0
86.2
—
10
113
(40768804) Tissue Pathology biopsy report
2903
27071
1.11
4.74
2.2
2.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
146
999
1.47
4.73
1.7
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
290
2225
1.31
4.72
1.5
1.5
u/l
10.4
9.0
1.01
233
1748
(3024891) Influenza virus A+B Ag [Presence] in Specimen
257
1942
1.33
4.66
1.2
1.2
—
—
—
0
0
(4306422)
151
1044
1.45
4.64
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
76
449
1.70
4.62
1.4
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
139
2007
0.69
4.62
1.6
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
116
1732
0.67
4.60
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
616
5171
1.21
4.59
3.9
4.2
ng/l
81.4
90.3
1.85
528
4481
(3006245) CD3-CD19+ cells/100 cells in Blood
63
356
1.77
4.49
2.7
2.8
%
10.4
12.3
0.47
58
336
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
37
175
2.12
4.42
1.4
1.4
nmol/l
117.4
132.2
0.22
27
128
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
106
1594
0.66
4.37
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
106
1589
0.66
4.31
1.3
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
22
83
2.65
4.31
2.1
2.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
106
1588
0.66
4.30
1.3
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
184
1338
1.38
4.30
1.3
1.4
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
57
317
1.80
4.30
1.1
1.1
u/ml
30.2
19.3
—
6
29
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
925
10540
0.86
4.30
1.3
1.2
u/ml
18.4
11.6
0.46
362
4074
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
107
1592
0.67
4.20
1.3
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
73
439
1.67
4.20
1.4
1.4
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
15
46
3.26
4.18
1.4
3.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
120
813
1.48
4.14
1.3
1.3
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
7
7
10.00
4.01
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
558
6580
0.84
3.97
1.5
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
34
164
2.08
3.90
1.4
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
298
2358
1.27
3.89
1.6
1.6
titre
473.8
309.7
0.26
13
99
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2195
23612
0.91
3.89
4.3
4.9
ug/l
3.2
3.3
0.08
1946
21202
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
118
808
1.47
3.88
1.6
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
186
2477
0.75
3.85
1.6
1.7
mg/l
5.1
3.8
0.63
140
1725
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
634
7373
0.85
3.84
1.7
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
145
1035
1.41
3.82
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
85
1297
0.65
3.81
1.4
1.4
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
19
71
2.68
3.81
1.1
1.2
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
7
8
8.75
3.77
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1731
18816
0.90
3.75
4.0
4.2
%
21.6
22.0
0.54
820
9062
(3017315) Amylase [Enzymatic activity/volume] in Urine
60
355
1.69
3.71
1.1
1.2
u/l
345.3
333.3
0.04
54
326
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
127
891
1.43
3.70
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
55
318
1.73
3.69
3.4
3.5
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
319
2564
1.25
3.68
1.2
1.2
u/ml
0.5
0.8
0.56
33
235
(3011648) Oxygen content in Venous blood
91
598
1.53
3.67
5.6
4.2
%
11.2
11.1
0.07
91
598
(3043238) Trisomy 21 risk [Likelihood] in Fetus
89
1332
0.66
3.65
1.4
1.5
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
110
753
1.47
3.65
1.2
1.1
%
91.8
95.4
0.81
99
708
(3001964) Herpes simplex virus Ag [Presence] in Specimen
40
211
1.90
3.61
1.6
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
900
7955
1.15
3.59
1.5
1.5
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
300
2402
1.26
3.58
2.2
2.3
g/l
3.2
3.1
0.98
212
1873
(3005033) Fetal Nuchal fold Thickness US
86
1290
0.66
3.58
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
178
2356
0.75
3.56
1.1
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
611
5252
1.18
3.54
4.5
4.3
%
0.3
0.3
0.03
188
1300
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
319
2577
1.25
3.53
2.1
2.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
249
1953
1.28
3.53
1.2
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
319
2579
1.25
3.51
2.1
2.2
g/l
7.2
7.4
1.04
216
1904
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
24
105
2.29
3.51
1.0
1.4
ng/l
43.5
74.7
0.58
15
69
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
128
909
1.41
3.51
1.3
1.3
nmol/l
0.2
0.3
—
10
52
(3014765) Yersinia sp identified in Stool by Organism specific culture
251
1973
1.28
3.50
1.2
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
33
165
2.00
3.47
1.2
1.2
pmol/l
375.5
285.4
0.57
25
118
(42529406) Shigella sp [Presence] in Stool by Culture
252
1984
1.28
3.47
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
146
1064
1.38
3.45
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
83
543
1.53
3.44
2.4
2.7
e6/l
665.7
658.3
0.03
37
196
(3023511) Choriogonadotropin [Units/volume] in Urine
169
1264
1.34
3.39
1.5
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
317
2575
1.24
3.36
2.1
2.2
g/l
3.7
3.8
0.67
210
1830
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
240
1897
1.27
3.23
1.4
1.5
iu/ml
15.4
14.2
—
6
43
(3006922) Hepatitis E virus Ab [Presence] in Serum
73
472
1.55
3.22
1.1
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
66
1019
0.64
3.20
1.1
1.1
u/ml
3.2
3.5
0.13
22
465
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
104
726
1.44
3.17
1.2
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
129
936
1.38
3.16
1.4
1.5
g/l
33.6
32.1
0.71
124
844
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1012
11230
0.89
3.16
1.2
1.3
iu/ml
30.2
31.4
0.09
265
3405
(3001122) Ferritin [Mass/volume] in Serum or Plasma
3190
30305
1.08
3.15
3.1
2.9
ug/l
139.6
126.1
1.41
2928
28098
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
52
311
1.68
3.14
1.3
1.6
nmol/l
2.2
5.8
1.35
43
248
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
46
266
1.73
3.14
2.7
2.5
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
270
2173
1.25
3.13
2.1
2.3
g/l
0.7
0.9
0.27
221
1864
(3033923) Metanephrine [Moles/time] in 24 hour Urine
27
131
2.06
3.11
1.2
1.1
umol/24h
0.8
0.7
0.29
11
62
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
68
437
1.56
3.09
1.5
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7475
73538
1.11
3.09
14.2
10.1
u/l
26.7
26.7
0.07
7288
70857
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
6400
65396
0.92
3.05
4.6
4.4
mmol/l
5.9
5.9
1.58
5854
59660
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
294
2402
1.23
2.99
2.2
2.3
g/l
10.2
10.2
0.11
230
2024
(21494815) CD4 cells/100 lymphocytes in Specimen
96
669
1.44
2.98
2.1
2.5
%
43.6
41.3
—
10
72
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
149
1119
1.34
2.96
1.1
1.2
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
256
2064
1.25
2.95
2.5
3.4
mg/l
31.2
53.3
2.37
224
1678
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
37
205
1.81
2.93
2.5
3.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
235
1878
1.26
2.92
1.3
1.3
titre
656.0
1003.4
—
5
53
(3034860) Kappa light chains.free [Mass/volume] in Serum
256
2066
1.25
2.92
2.5
3.4
mg/l
48.2
86.5
0.75
224
1677
(40763480) Human metapneumovirus Ag [Presence] in Specimen
11
35
3.14
2.92
1.5
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
240
1924
1.25
2.91
2.0
2.2
g/l
0.0
0.0
0.11
208
1758
(3015076) Soybean IgE Ab [Units/volume] in Serum
21
431
0.49
2.88
1.1
1.1
u/ml
1.7
1.7
—
5
80
(3027540) Rickettsia typhi Ab [Titer] in Serum
6
9
6.67
2.86
1.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
20
89
2.25
2.86
1.2
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
44
259
1.70
2.85
3.0
2.7
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
21
96
2.19
2.82
1.2
1.1
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
49
299
1.64
2.78
1.6
1.5
iu/ml
1963000.0
1683834.0
—
5
19
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
223
1784
1.26
2.77
2.1
2.2
g/l
0.0
0.0
0.45
191
1626
(3007566) Smooth muscle Ab [Titer] in Serum
235
1892
1.25
2.76
1.3
1.3
titre
124.8
151.3
0.16
23
163
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
113
823
1.38
2.76
1.8
2.1
mg/l
49.4
24.2
2.01
27
205
(3000060) B lymphocytes [#/volume] in Blood
46
277
1.66
2.75
2.7
2.8
e6/l
980.4
262.8
0.41
23
162
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
5
6
8.33
2.75
1.2
1.3
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
5
6
8.33
2.75
1.2
1.3
—
—
—
0
0
(4094501)
135
1781
0.75
2.73
1.1
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
7682
77748
0.90
2.72
32.9
20.7
g/l
132.7
135.7
59.26
7592
76594
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
16
66
2.43
2.70
1.6
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
100
717
1.40
2.68
1.1
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
7681
77729
0.90
2.68
32.7
20.6
e12/l
4.4
4.5
84.80
7518
75402
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
248
2018
1.24
2.66
2.5
3.3
ratio
20.1
2.4
0.44
26
155
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
55
350
1.57
2.66
2.3
1.8
u/field
1.4
3.3
1.75
44
248
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
25
126
1.99
2.64
1.2
1.2
mg/l
0.9
140.0
1.44
15
97
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
143
1088
1.32
2.64
1.2
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
27
140
1.93
2.64
1.7
1.3
—
—
—
0
0
(3024731) MCV [Entitic volume]
7681
77718
0.90
2.62
32.6
20.5
fl
91.0
90.7
8.12
7589
76561
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
73
496
1.48
2.62
1.4
1.5
u/l
13.2
12.9
0.12
73
475
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
135
1020
1.33
2.62
1.2
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
7681
77714
0.90
2.60
32.5
20.5
pg
30.5
30.2
25.13
7588
76558
(3010813) Leukocytes [#/volume] in Blood
7685
77747
0.90
2.58
32.7
20.6
e9/l
6.8
6.8
0.91
7526
75403
(3023199) Leukocytes [#/volume] in Pleural fluid
113
835
1.36
2.55
1.4
1.5
e6/l
2465.1
2305.0
0.12
96
604
(3042111) Morphology [Interpretation] in Bone marrow Narrative
149
1149
1.30
2.51
1.7
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
243
1987
1.23
2.51
2.0
2.1
g/l
37.1
37.6
0.45
200
1705
(3038177) Helicobacter pylori Ab [Presence] in Serum
80
1127
0.71
2.49
1.2
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
72
494
1.46
2.48
1.2
1.3
u/l
12.2
12.8
0.18
67
452
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
52
333
1.56
2.47
1.9
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
52
333
1.56
2.47
1.9
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
52
333
1.56
2.47
1.9
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
52
333
1.56
2.47
1.9
2.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
8
21
3.81
2.46
1.5
1.4
nmol/l
521.9
523.3
—
8
21
(3033086) Enterovirus NOS Ab [Titer] in Serum
8
21
3.81
2.46
1.1
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
332
2805
1.19
2.46
1.8
1.9
u/l
39.1
39.0
0.02
298
2484
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
217
1758
1.24
2.45
2.1
2.2
g/l
0.0
0.0
0.00
191
1621
(3020874) Milk IgE Ab [Units/volume] in Serum
28
496
0.56
2.45
1.1
1.2
u/ml
0.8
3.6
1.90
12
202
(4010399)
539
4735
1.15
2.43
1.5
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
124
937
1.33
2.43
1.6
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
102
750
1.36
2.39
1.4
1.5
e6/l
68048.7
58188.1
0.14
77
438
(3014599) Egg white IgE Ab [Units/volume] in Serum
28
492
0.57
2.39
1.2
1.2
u/ml
1.6
8.6
—
8
180
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
9
27
3.33
2.39
1.0
1.1
mg/l
0.1
0.0
—
9
20
(3003694) ABO and Rh group [Type] in Blood
2070
19517
1.08
2.38
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
7681
77667
0.90
2.38
32.7
20.6
e9/l
248.1
249.9
1.50
7537
75556
(3019897) Erythrocyte distribution width [Ratio] by Automated count
59
869
0.68
2.37
3.9
2.6
%
13.5
13.1
1.54
59
857
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
46
290
1.59
2.35
1.2
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
40
244
1.64
2.33
1.2
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
33
191
1.73
2.32
1.1
1.3
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
52
340
1.53
2.28
32.0
36.7
ug/l
7.0
7.3
0.31
46
315
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
27
148
1.83
2.27
2.7
2.7
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
59
398
1.49
2.24
1.0
1.1
nmol/l
0.1
10.8
—
8
88
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
113
1481
0.76
2.24
1.5
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
668
7434
0.89
2.23
1.3
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
41
255
1.61
2.23
2.1
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
41
255
1.61
2.23
2.1
2.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
41
257
1.60
2.16
2.1
2.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
30
173
1.74
2.16
1.2
1.1
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
6
14
4.29
2.15
1.0
1.1
mg/l
24.6
74.1
—
6
14
(3007164) IgA [Mass/volume] in Serum or Plasma
1476
13787
1.08
2.14
1.5
1.5
g/l
2.3
2.4
0.73
878
8308
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
95
705
1.35
2.14
1.3
1.3
—
36.1
—
0
8
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
16
74
2.16
2.14
3.7
2.4
u/field
0.4
0.6
0.67
16
74
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
243
2029
1.20
2.10
2.1
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
114
873
1.31
2.08
1.4
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
112
856
1.31
2.08
1.4
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
49
324
1.51
2.07
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
49
324
1.51
2.07
1.4
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
80
582
1.38
2.05
1.2
1.3
titre
223.1
189.9
0.13
13
113
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
80
582
1.38
2.05
1.2
1.3
—
147.8
—
0
23
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1651
15517
1.08
2.05
1.3
1.3
u/ml
1.5
2.0
1.15
441
4035
(3012920) Ethanol [Mass/volume] in Serum or Plasma
6
15
4.00
2.03
1.3
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
111
852
1.31
2.01
1.4
1.5
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
14
63
2.22
2.00
10.4
8.5
—
—
—
0
0
(3002256) Pathology report gross observation
796
8717
0.90
2.00
1.2
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
35
216
1.62
1.99
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
97
733
1.33
1.97
1.4
1.5
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
7
21
3.33
1.96
1.1
4.5
—
—
—
0
0
(3032641) Amino acids panel - Urine
7
21
3.33
1.96
1.1
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
13
270
0.48
1.95
1.0
1.2
u/ml
11.2
17.0
—
7
172
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
12
51
2.35
1.94
1.3
1.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
28
164
1.71
1.93
1.3
1.5
g/l
11.8
13.6
0.38
23
129
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
87
1153
0.75
1.92
1.4
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
63
446
1.42
1.91
1.1
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
13
58
2.24
1.90
1.1
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
901
8285
1.10
1.89
1.7
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
175
1432
1.23
1.88
1.4
1.6
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
63
448
1.41
1.87
1.1
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
28
2.86
1.86
1.0
1.6
—
—
—
0
0
(3034426) Prothrombin time (PT)
39
252
1.55
1.86
1.3
1.2
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
16
79
2.03
1.84
4.1
3.7
%
10.3
3.9
—
9
33
(40760888) Immunoglobulin light chains.free panel - Serum
190
1572
1.21
1.84
2.7
3.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
110
855
1.29
1.84
1.4
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
226
1902
1.19
1.83
1.4
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
42
277
1.52
1.83
1.0
1.3
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
74
545
1.36
1.80
2.3
2.1
u/field
2.0
1.6
0.22
38
213
(3024522) Salmonella sp identified in Specimen by Organism specific culture
110
858
1.29
1.80
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
110
858
1.29
1.80
1.4
1.5
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
27
161
1.68
1.77
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
120
951
1.27
1.74
1.5
1.5
nmol/l
0.3
0.4
0.13
96
752
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
102
792
1.29
1.74
2.6
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
97
749
1.30
1.73
1.3
1.2
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
5
13
3.85
1.71
1.8
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
164
1349
1.22
1.71
1.8
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
120
954
1.26
1.70
1.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
232
1973
1.18
1.69
1.4
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
25
148
1.69
1.69
1.2
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
25
148
1.69
1.69
1.4
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
95
734
1.30
1.69
1.4
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
140
1135
1.24
1.68
1.2
1.1
iu/ml
8684.7
8254.9
0.01
30
286
(3019420) Tryptase [Mass/volume] in Serum or Plasma
52
366
1.42
1.67
1.4
1.5
ug/l
5.8
7.7
1.42
46
324
(3029075) Extractable nuclear Ab panel - Serum
10
213
0.47
1.65
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
37
244
1.52
1.64
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
24
142
1.69
1.64
1.8
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
887
9551
0.92
1.58
1.4
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
495
4461
1.12
1.58
1.2
1.2
iu/ml
88.9
145.4
3.57
183
1621
(3022621) pH of Urine by Test strip
498
4495
1.11
1.55
3.7
2.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
54
389
1.39
1.54
1.6
3.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
12
57
2.11
1.54
1.1
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
12
57
2.11
1.54
2.3
2.7
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
13
64
2.03
1.53
1.6
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
35
232
1.51
1.53
2.1
2.1
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
30
192
1.56
1.53
1.2
1.3
ug/l
19.1
309.2
1.28
18
96
(3020682) Albumin/Creatinine [Ratio] in Urine
1962
20522
0.94
1.53
3.8
4.0
mg/mmol
11.8
9.8
0.83
1284
13263
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1241
13171
0.93
1.52
1.6
1.6
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
43
298
1.44
1.52
1.1
1.1
%
94.5
92.9
0.11
34
232
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
5
15
3.33
1.52
1.0
1.0
g/l
183.2
157.9
—
5
15
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
36
241
1.50
1.51
1.3
1.2
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
41
282
1.46
1.51
1.9
2.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
12
58
2.07
1.48
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
22
131
1.68
1.48
1.4
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
22
131
1.68
1.48
1.4
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
84
652
1.29
1.48
1.5
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
113
910
1.24
1.48
2.5
2.9
—
—
—
0
0
(3004451) EKG impression Narrative
47
334
1.41
1.46
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
151
1807
0.83
1.46
1.4
1.4
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
7
28
2.50
1.45
1.0
1.3
nmol/l
217.9
307.7
—
7
28
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
14
73
1.92
1.43
4.1
3.4
mg/l
1.5
1.4
—
9
54
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
79
612
1.29
1.43
1.4
1.4
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
9
39
2.31
1.42
1.0
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
520
4730
1.11
1.42
3.3
2.8
e9/l
4.0
4.1
0.55
389
3701
(3001186) Copper [Moles/volume] in Serum or Plasma
26
164
1.59
1.42
1.1
1.4
umol/l
16.1
16.5
0.13
21
149
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
103
827
1.25
1.40
1.1
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
20
326
0.61
1.40
1.7
1.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
249
2171
1.15
1.38
5.9
6.2
mg/l
1.5
1.5
0.14
227
2019
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
45
322
1.40
1.37
1.2
1.1
u/l
31.0
28.9
0.09
31
242
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
42
585
0.72
1.37
1.3
1.3
pmol/l
165.2
115.4
0.16
17
179
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
5
17
2.94
1.36
1.0
2.3
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
5
17
2.94
1.36
1.0
1.3
mmol/l
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
5
17
2.94
1.36
1.2
2.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
14
75
1.87
1.34
1.2
1.1
u/ml
0.0
0.7
—
8
44
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
329
2930
1.13
1.33
1.1
1.1
u/ml
1.1
9.6
—
9
42
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
110
1343
0.82
1.33
2.0
1.8
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
45
324
1.39
1.33
1.2
1.1
u/l
104.4
86.8
0.56
35
252
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
66
505
1.31
1.32
2.0
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1382
13117
1.06
1.32
1.8
1.9
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
147
0.48
1.31
1.1
1.1
u/ml
10.8
55.3
—
7
140
(3023487) Leukocytes [#/volume] in Peritoneal fluid
34
233
1.46
1.31
1.9
2.1
e6/l
632.0
3933.3
0.52
28
169
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
67
515
1.30
1.30
1.1
1.1
mg/l
283.4
283.9
0.02
60
459
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
33
225
1.47
1.30
1.2
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
35
497
0.70
1.29
1.1
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
19
306
0.62
1.28
1.6
1.5
%
3.3
4.1
—
7
71
(3010726) Horse dander IgE Ab [Units/volume] in Serum
110
1337
0.82
1.28
1.1
1.1
u/ml
2.1
2.7
0.23
30
363
(40768793) Breast Pathology biopsy report
106
1293
0.82
1.28
1.3
1.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
31
210
1.48
1.27
1.5
1.9
e6/l
13508.9
15323.4
0.05
21
120
(3014133) Dog dander IgE Ab [Units/volume] in Serum
85
1060
0.80
1.27
1.1
1.1
u/ml
2.1
4.2
1.69
44
461
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
192
1655
1.16
1.26
1.9
1.8
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
8
35
2.29
1.26
1.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
30
436
0.69
1.26
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
399
4397
0.90
1.23
1.2
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
21
131
1.60
1.23
1.4
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
64
495
1.29
1.21
1.8
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
62
797
0.78
1.20
1.7
1.6
%
56.0
59.2
0.29
48
513
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
36
255
1.41
1.19
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
75
940
0.80
1.19
1.3
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
33
230
1.44
1.19
1.5
1.4
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
166
1926
0.86
1.17
1.1
1.1
u/ml
6.2
7.3
0.13
12
240
(3013293) Extractable nuclear Ab [Presence] in Serum
16
94
1.70
1.17
1.7
1.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
49
367
1.34
1.17
1.7
1.4
nmol/l
1.1
1.2
0.54
39
278
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
136
1602
0.85
1.16
1.2
1.1
u/ml
1.4
2.1
0.58
61
740
(3022493) Free Hemoglobin [Mass/volume] in Plasma
43
316
1.36
1.16
8.0
5.4
mg/l
79.1
66.2
0.64
37
222
(3017400) Magnesium [Moles/volume] in Urine
5
20
2.50
1.15
1.0
1.1
mmol/l
2.8
2.8
—
5
15
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
8
39
2.05
1.15
1.0
1.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
75
935
0.80
1.14
1.3
1.3
mmol/l
6.9
7.2
0.32
53
680
(37021550) Renin [Units/volume] in Plasma --upright
24
158
1.52
1.14
1.3
1.3
mu/l
165.3
113.6
0.28
19
124
(3008536) Aspergillus sp Ab [Presence] in Serum
21
134
1.57
1.13
3.1
2.3
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
7
30
2.33
1.12
1.0
1.1
—
23.6
—
0
7
(3013166) Neutrophils/100 leukocytes in Synovial fluid
30
208
1.44
1.12
1.3
1.3
%
58.0
54.8
0.17
21
172
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
11
58
1.90
1.11
1.4
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
971
9170
1.07
1.11
1.4
1.3
titre
495.6
519.9
0.18
197
1831
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
204
1788
1.14
1.11
1.9
2.0
mg/l
11.6
11.4
0.14
184
1665
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
71
886
0.80
1.10
1.1
1.1
u/ml
0.0
0.5
2.75
15
254
(3023323) Follitropin [Units/volume] in Serum or Plasma
335
3033
1.11
1.07
1.5
1.4
iu/l
29.2
25.8
0.96
265
2522
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
11
59
1.86
1.07
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1734
18019
0.95
1.06
2.9
2.7
umol/l
2909.7
4395.1
0.99
1480
15656
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
10
180
0.55
1.06
1.6
1.9
—
140.9
—
0
21
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
84
685
1.23
1.06
1.1
1.2
u/l
68.4
73.0
0.14
59
458
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
35
253
1.38
1.06
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
247
2765
0.89
1.05
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
613
5710
1.08
1.05
1.2
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
66
525
1.26
1.04
1.9
2.0
mmol/l
8.0
6.5
2.05
48
369
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
23
154
1.49
1.03
1.1
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
68
842
0.81
1.01
1.1
1.4
ug/l
2.7
4.3
2.39
58
757
(3045683) HLA typing for celiac disease panel - Blood or Tissue
30
415
0.72
1.00
1.0
1.0
—
—
—
0
0
(4024509)
79
645
1.23
1.00
1.8
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
26
368
0.71
0.99
2.0
2.1
ug/min
155.3
173.2
—
6
90
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
16
99
1.62
0.99
1.4
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
92
764
1.21
0.99
1.4
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
58
458
1.27
0.98
1.2
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
5
23
2.17
0.98
1.0
1.1
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
7
36
1.94
0.97
1.1
1.4
pmol/l
22.4
24.5
—
7
27
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
58
726
0.80
0.96
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
73
596
1.23
0.94
1.3
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
11
62
1.77
0.94
1.2
1.2
umol/24h
2.4
1.6
0.67
11
62
(3011841) English Walnut IgE Ab [Units/volume] in Serum
6
118
0.51
0.93
1.0
1.1
u/ml
0.0
9.6
—
6
97
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
19
125
1.52
0.93
1.9
1.5
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
6
120
0.50
0.93
1.0
1.2
u/ml
0.1
5.3
—
6
97
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
74
606
1.22
0.93
4.0
4.9
u/ml
294.7
69.5
0.69
17
174
(3012516) Albumin [Mass/volume] in Urine
1888
19516
0.96
0.93
3.2
3.3
mg/l
559.0
391.8
0.70
1266
12626
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
4502
45767
0.97
0.91
3.2
3.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
75
907
0.83
0.91
2.2
2.7
umol/l
4.9
8.7
2.71
53
669
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
194
2179
0.89
0.91
1.5
1.6
iu/ml
85.4
6.9
0.62
52
465
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
142
1235
1.15
0.91
3.1
3.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
28
201
1.39
0.90
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
389
3584
1.09
0.90
2.5
2.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
197
1752
1.13
0.90
5.3
4.1
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
14
86
1.63
0.90
1.4
1.1
—
—
—
0
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
11
63
1.75
0.90
2.3
1.7
mg/l
2.9
1.6
—
6
47
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
11
63
1.75
0.90
2.3
1.7
mg/l
1.3
1.0
—
5
43
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
11
63
1.75
0.90
2.3
1.7
mg/l
0.6
1.5
—
5
41
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
11
63
1.75
0.90
2.3
1.7
mg/l
0.8
0.9
—
5
44
(3010375) cycloSPORINE [Mass/volume] in Blood
48
376
1.28
0.89
22.9
26.5
ug/l
110.2
119.2
0.46
38
315
(3003338) MCHC [Mass/volume]
6072
60011
1.04
0.89
29.3
17.9
g/l
334.3
332.8
28.54
6020
59481
(3035880) pH of Pleural fluid
49
385
1.27
0.88
1.2
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
17
111
1.53
0.87
1.2
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
121
1396
0.86
0.86
1.1
1.1
u/ml
0.5
1.1
2.30
52
685
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
98
833
1.18
0.85
1.9
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
47
370
1.27
0.84
1.4
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
47
370
1.27
0.84
1.4
1.8
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
48
379
1.27
0.84
1.5
1.4
umol/l
5.1
4.6
0.41
43
350
(3003888) Timothy IgE Ab [Units/volume] in Serum
125
1436
0.87
0.84
1.1
1.1
u/ml
4.0
6.4
1.45
64
811
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
224
2480
0.90
0.83
1.6
1.7
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
375
3465
1.09
0.83
1.2
1.1
titre
140.6
161.2
—
8
97
(3000570) Elastase.pancreatic [Mass/mass] in Stool
222
2001
1.11
0.83
1.4
1.4
ug/g
258.3
278.0
0.76
126
1159
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
35
266
1.32
0.82
1.2
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
132
1154
1.15
0.81
1.5
1.6
g/l
0.7
0.8
0.71
103
883
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
107
922
1.16
0.80
1.1
1.1
g/l
1.5
1.5
0.08
100
826
(3027456) Digoxin [Moles/volume] in Serum or Plasma
148
1306
1.14
0.80
3.6
3.1
nmol/l
0.7
0.8
4.02
115
986
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
138
1566
0.88
0.79
1.2
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
50
401
1.25
0.79
1.2
1.2
ratio
1.1
1.1
1.09
21
136
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
39
497
0.78
0.79
1.5
1.6
mmol/l
6.9
7.7
1.03
20
299
(3036071) Salmonella sp Ab [Titer] in Serum
31
233
1.33
0.79
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
104
1203
0.86
0.78
1.6
1.5
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
11
66
1.67
0.78
2.3
1.8
mg/l
1.0
1.2
—
5
45
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.2
—
0.2
—
0
20
(3005322) IgE [Units/volume] in Serum or Plasma
471
4406
1.07
0.78
1.3
1.3
u/ml
143.9
239.7
4.60
430
4090
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
74
1.62
0.78
1.1
1.3
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
6
34
1.76
0.76
3.0
5.9
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
22
157
1.40
0.76
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
56
458
1.22
0.75
1.2
1.2
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
12
75
1.60
0.74
1.2
1.1
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
5
24
2.08
0.74
1.2
1.2
u/field
1.0
1.5
—
5
12
(3023430) Cat dander IgE Ab [Units/volume] in Serum
85
993
0.85
0.74
1.1
1.1
u/ml
6.8
5.9
0.11
46
441
(3021879) Hepatitis B virus core Ab [Presence] in Serum
566
5339
1.06
0.74
1.5
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
90
1044
0.86
0.72
1.4
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
39
1.79
0.72
1.1
1.3
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
107
0.56
0.72
1.3
3.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
53
644
0.82
0.72
1.1
1.2
—
—
—
0
0
(4212803)
11
68
1.62
0.71
1.1
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
5
26
1.92
0.70
1.2
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
55
453
1.22
0.70
1.2
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
99
1137
0.87
0.70
1.1
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
15
101
1.49
0.70
1.7
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
59
490
1.21
0.70
2.6
2.3
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.69
2.7
1.2
—
—
—
0
0
(44806071)
13
85
1.53
0.68
1.2
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
13
85
1.53
0.68
2.5
4.5
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
27
204
1.32
0.68
1.1
1.0
—
—
—
0
0
(40758358) Immune stain study
5
27
1.85
0.68
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
45
365
1.23
0.67
1.6
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
43
1.63
0.66
1.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
34
267
1.27
0.66
1.1
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
484
4564
1.06
0.66
1.9
2.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
36
451
0.80
0.66
1.3
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
76
650
1.17
0.66
1.3
1.4
mmol/l
6.3
6.4
0.16
70
600
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
75
641
1.17
0.66
3.3
3.8
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
44
1.59
0.65
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
126
1120
1.13
0.65
1.5
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
100
1137
0.88
0.63
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
27
207
1.30
0.63
2.3
1.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
38
305
1.25
0.63
1.6
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
387
3631
1.07
0.63
1.8
1.9
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
621
5912
1.05
0.62
4.4
3.9
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
59
497
1.19
0.62
2.3
1.6
u/ml
32.5
23.1
0.77
16
107
(3004716) Salmonella sp identified in Stool by Organism specific culture
373
3501
1.07
0.60
1.3
1.3
—
—
—
0
0
(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.1
—
223.1
—
0
15
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
20
0.00
0.60
0.0
7.7
—
—
—
0
0
(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
15.9
—
0
15
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
88
769
1.15
0.60
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
49
408
1.20
0.59
1.5
1.6
u/l
4.1
6.1
0.65
23
200
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
179
1958
0.91
0.59
1.4
1.4
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
21
157
1.34
0.58
6.0
6.1
%
70.7
73.0
0.17
16
124
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
23
0.00
0.58
0.0
1.1
—
2.8
—
0
23
(3022670) pH of Venous cord blood
6
35
1.71
0.57
1.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
8
55
1.45
0.56
1.1
1.1
u/l
12.0
15.7
—
8
55
(3016650) Hepatitis A virus Ab [Presence] in Serum
129
1162
1.11
0.55
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
76
662
1.15
0.55
1.5
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
417
3944
1.06
0.55
1.2
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
707
6781
1.05
0.55
3.9
4.1
ug/l
12.8
28.4
1.55
576
5499
(21494890) Protein electrophoresis panel - 24 hour Urine
77
672
1.15
0.55
1.6
2.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
27
340
0.79
0.54
1.1
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
70
607
1.15
0.54
1.1
1.2
nmol/l
308.5
357.1
1.46
51
503
(3050794) Legionella sp Ab [Presence] in Serum
9
60
1.50
0.54
1.1
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
9
61
1.48
0.53
1.7
1.6
umol/l
59.1
42.9
—
9
61
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
802
8322
0.96
0.53
2.1
2.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
649
6758
0.96
0.51
1.6
1.7
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
30
242
1.24
0.50
1.4
1.2
g/l
0.3
0.3
0.36
25
193
(3010937) Rubella virus Ab [Presence] in Serum
6
41
1.46
0.50
1.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
21
269
0.78
0.50
1.4
1.5
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
5861
58133
1.02
0.49
26.7
17.1
%
13.7
13.7
0.30
5771
56852
(3041918) Cholesterol [Moles/volume] in Pleural fluid
18
136
1.32
0.49
1.1
1.2
mmol/l
1.8
1.6
0.41
12
84
(3047007) Chlamydophila sp Ab [Presence] in Serum
90
1007
0.89
0.48
1.3
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
90
1005
0.89
0.47
2.7
2.9
u/ml
2392.1
421.1
0.39
85
956
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
122
1339
0.91
0.47
1.3
1.2
u/ml
59.1
40.9
0.54
22
131
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
15
111
1.35
0.46
1.4
1.7
ng/l
112.9
150.0
0.51
15
111
(3025577) Chromium [Mass/volume] in Blood
33
397
0.83
0.46
1.9
2.1
ug/l
2.1
2.3
0.19
25
330
(40761995) Spermatozoa Progressive [#/volume] in Semen
28
227
1.23
0.46
2.0
3.1
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
16
120
1.33
0.46
1.1
1.1
—
5.2
—
0
19
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
26
320
0.81
0.45
1.1
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
170
1574
1.08
0.44
1.6
1.8
iu/l
3.2
4.5
1.84
53
559
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
32
384
0.83
0.44
1.3
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
125
1364
0.91
0.43
3.0
3.5
u/ml
290.0
643.0
0.81
113
1248
(4146454)
62
703
0.88
0.43
2.3
2.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
77
861
0.89
0.43
1.5
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
122
1116
1.09
0.43
1.4
1.2
u/l
65.2
39.3
0.64
106
975
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
11
151
0.73
0.42
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
46
532
0.86
0.42
1.2
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
29
349
0.83
0.42
7.5
5.5
u/ml
1969.8
10323.2
—
5
65
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
6
95
0.63
0.42
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1867
18313
1.02
0.41
4.1
3.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
13
96
1.35
0.41
1.1
1.2
—
—
—
0
0
(3035082) Kappa light chains [Mass/volume] in Urine
0
16
0.00
0.41
0.0
1.1
—
0.0
—
0
5
(3034614) HLA Ag [Interpretation]
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
42
487
0.86
0.40
1.0
1.1
iu/ml
12.8
9.2
—
8
115
(3024263) Appearance of Synovial fluid
31
369
0.84
0.40
1.5
1.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
70
624
1.12
0.40
1.4
1.3
e6/l
153096.4
114669.2
0.20
48
427
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
128
1179
1.09
0.40
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
13
171
0.76
0.39
1.2
1.5
—
—
—
0
0
(4281824)
57
643
0.89
0.38
1.4
1.2
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
32
377
0.85
0.38
2.2
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
35
408
0.86
0.37
1.3
1.5
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
37
1.35
0.37
1.0
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
86
781
1.10
0.37
1.4
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
67
600
1.12
0.37
1.5
1.3
nmol/l
1.5
1.5
0.16
59
539
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
52
588
0.88
0.36
1.3
1.3
mmol/l
8.8
11.9
1.71
13
150
(3023420) DNA double strand Ab [Units/volume] in Serum
77
696
1.11
0.36
2.3
1.4
iu/ml
30.2
23.1
—
5
29
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
28
332
0.84
0.36
1.0
1.1
—
—
—
0
0
(4015189)
13
168
0.77
0.35
1.5
2.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
17
212
0.80
0.35
1.2
1.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
18
222
0.81
0.34
1.9
1.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
27
227
1.19
0.34
4.1
6.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
81
738
1.10
0.34
1.3
1.3
g/l
0.4
0.4
0.07
62
527
(3028192) IgG subclass 2 [Mass/volume] in Serum
81
739
1.10
0.33
1.3
1.3
g/l
2.8
2.9
0.11
63
529
(3027135) IgG subclass 1 [Mass/volume] in Serum
81
739
1.10
0.33
1.3
1.3
g/l
6.4
6.6
0.22
64
525
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
32
371
0.86
0.33
2.2
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
70
771
0.91
0.33
1.5
1.7
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
89
0.67
0.32
1.0
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
933
9109
1.03
0.32
1.2
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
842
8628
0.97
0.32
2.1
2.5
ug/g
152.4
133.2
0.56
667
6837
(3000285) Sodium [Moles/volume] in Blood
12
92
1.30
0.31
1.2
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
30
348
0.86
0.31
5.1
4.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
21
174
1.21
0.31
1.2
1.2
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
7
52
1.35
0.31
1.0
2.5
—
76.9
—
0
22
(4062490)
81
743
1.09
0.30
1.4
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
55
610
0.90
0.30
1.5
1.5
%
32.5
29.5
0.27
40
378
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
18
218
0.83
0.30
2.2
1.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
2123
21510
0.98
0.30
3.4
3.3
mmol/l
7.6
7.7
0.65
1804
18178
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1099
10768
1.02
0.29
1.7
1.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
59
649
0.91
0.28
3.3
3.1
mg/l
84.3
57.5
0.25
43
496
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
42
470
0.89
0.27
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
270
2590
1.04
0.27
2.3
2.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
15
183
0.82
0.27
2.3
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
149
1574
0.95
0.26
2.3
2.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
15
182
0.82
0.26
6.6
7.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
12
95
1.26
0.26
1.6
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
33
291
1.13
0.25
1.0
1.1
u/ml
1.6
7.1
—
5
49
(3044007) Cell count panel - Peritoneal fluid
22
188
1.17
0.25
1.5
1.9
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
14
114
1.23
0.25
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
14
114
1.23
0.25
1.4
1.5
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
9
75
1.20
0.25
1.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
37
330
1.12
0.24
2.4
3.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
60
551
1.09
0.24
1.8
1.6
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
6
81
0.74
0.24
1.2
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
28
318
0.88
0.24
1.2
1.7
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
25
286
0.87
0.23
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
307
2966
1.04
0.23
1.2
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
164
1563
1.05
0.23
1.6
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
176
1681
1.05
0.23
2.3
2.4
ug/min
165.0
108.8
0.83
98
1026
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
66
610
1.08
0.23
1.1
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
38
1.32
0.23
1.0
1.7
—
—
—
0
0
(3024471) HLA-A [Type]
29
256
1.13
0.23
1.0
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
221
2126
1.04
0.22
1.4
1.3
miu/ml
185.0
215.2
0.58
85
951
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.1
—
124.5
—
0
10
(3015350) Toxocara sp Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
11
0.00
0.21
0.0
7.5
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3020934) Sesame Seed IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
12.6
—
0
5
(3028714) Urate [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
12
0.00
0.21
0.0
1.2
—
70.7
—
0
12
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
7.0
—
0.3
—
0
12
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
8
105
0.76
0.21
1.0
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
149
1423
1.05
0.21
1.9
1.9
nmol/l
0.9
0.8
0.78
119
1189
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
149
1423
1.05
0.21
1.5
1.6
u/ml
107.6
114.2
0.34
33
280
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
0
13
0.00
0.21
0.0
7.9
—
60.6
—
0
5
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
13
0.00
0.21
0.0
1.2
—
40.1
—
0
13
(3006969) Lambda light chains [Mass/volume] in Urine
0
14
0.00
0.20
0.0
1.1
—
0.0
—
0
7
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
17
146
1.16
0.19
1.4
2.1
mmol/l
6.0
8.1
2.66
12
87
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
20
175
1.14
0.18
2.0
1.9
nmol/l
0.1
0.2
1.74
14
124
(3017446) Testosterone [Moles/volume] in Serum or Plasma
559
5700
0.98
0.18
2.1
2.2
nmol/l
12.4
12.6
0.30
488
5009
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
11
132
0.83
0.18
1.1
1.7
ug/l
1.8
2.0
—
6
70
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
27
300
0.90
0.18
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
47
507
0.93
0.17
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
28
252
1.11
0.17
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
174
1804
0.96
0.17
1.4
1.2
u/ml
50.0
37.5
0.32
22
101
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
7
62
1.13
0.17
1.0
1.0
g/l
162.6
163.5
—
7
62
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
47
506
0.93
0.17
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
47
506
0.93
0.17
1.2
1.2
—
—
—
0
0
(3036603) Volume of Urine
41
444
0.92
0.17
1.7
1.7
ml
2092.3
1874.2
—
10
107
(3042733) HLA Ab [Presence] in Serum
28
253
1.11
0.16
4.4
4.6
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
53
495
1.07
0.16
1.2
1.2
u/ml
55.3
74.4
—
6
20
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
68
641
1.06
0.16
1.2
1.4
—
—
—
0
0
(4133840)
22
196
1.12
0.16
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
47
504
0.93
0.16
1.2
1.2
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
6
78
0.77
0.15
1.7
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
262
2551
1.03
0.15
2.2
1.8
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
17
149
1.14
0.15
1.6
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
240
2334
1.03
0.15
1.7
1.8
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
47
503
0.93
0.15
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
47
503
0.93
0.15
1.2
1.2
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
79
1.14
0.15
1.3
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
24
265
0.91
0.15
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
98
1023
0.96
0.14
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
42
391
1.07
0.14
5.9
6.7
—
—
—
0
0
(4211845)
39
362
1.08
0.14
2.3
3.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
53
499
1.06
0.14
1.2
1.2
u/ml
26.9
48.8
—
7
38
(3000330) Specific gravity of Urine by Test strip
352
3450
1.02
0.13
4.2
3.4
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
17
151
1.13
0.13
1.4
1.5
ug/l
0.3
0.4
—
8
92
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
131
1354
0.97
0.13
1.4
1.2
u/ml
1.5
4.4
—
10
92
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
44
413
1.07
0.12
1.4
1.5
u/l
11.4
6.4
0.46
36
356
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
13
148
0.88
0.12
3.8
2.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
13
148
0.88
0.12
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
252
2466
1.02
0.11
1.3
1.3
—
—
—
0
0
(44806420)
17
188
0.90
0.11
2.4
2.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
746
7538
0.99
0.10
2.0
2.0
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
50
476
1.05
0.10
1.2
1.2
u/ml
3.0
12.4
—
5
31
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
163
1669
0.98
0.10
1.4
1.3
u/ml
14.7
8.6
0.47
38
251
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
47
1.06
0.09
4.2
3.9
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
158
1543
1.02
0.09
1.3
1.2
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.0
u/ml
23.7
13.8
—
5
39
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
17
186
0.91
0.09
1.4
1.5
ug/l
10.8
8.9
0.57
17
186
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
6
57
1.05
0.08
2.7
5.1
—
—
—
0
0
(3001729) Color of Synovial fluid
5
62
0.81
0.08
1.0
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
64
0.78
0.08
1.2
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
216
2197
0.98
0.08
1.7
1.8
nmol/l
48.3
40.5
2.52
211
2130
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(44813793)
53
510
1.04
0.07
1.1
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
7
82
0.85
0.07
1.1
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
153
1558
0.98
0.07
2.0
1.9
pmol/l
190.9
203.9
0.90
144
1469
(3016750) Collection duration of Urine
38
397
0.96
0.07
2.3
2.2
min
494.1
492.4
0.03
28
293
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
163
1601
1.02
0.06
1.3
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
92
0.87
0.06
17.5
9.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
92
0.87
0.06
17.5
12.5
mmol/l
4.7
5.7
—
8
92
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
162
1648
0.98
0.06
1.4
1.3
u/ml
4.4
5.3
0.13
26
154
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
12
132
0.91
0.06
1.1
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
155
1522
1.02
0.06
1.2
1.4
u/ml
262.7
255.7
0.13
104
919
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
14
128
1.09
0.06
7.0
8.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
6383
63732
1.00
0.06
19.2
13.1
ml/min/173m2
86.9
81.8
55.68
5411
52382
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
45
433
1.04
0.06
1.5
1.3
titre
113.3
339.2
—
6
38
(3043410) Blood group antigens tested for on Red Blood Cells
18
193
0.93
0.06
2.1
1.8
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
297
3003
0.99
0.06
3.1
3.4
u/ml
140.3
55.4
0.40
287
2892
(40758292) HTLV I+II Ab panel - Serum
13
119
1.09
0.06
1.5
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
223
2258
0.99
0.05
1.4
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
18
192
0.94
0.05
1.6
1.4
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
18
169
1.06
0.05
3.3
2.9
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
19
201
0.94
0.04
6.3
7.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
150
1520
0.99
0.04
5.0
3.4
mg/l
28.3
27.4
0.12
96
950
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
241
2388
1.01
0.04
2.9
3.5
u/ml
190.2
2747.5
1.41
206
2032
(3045414) Leukocytes [Presence] in Urine
306
3036
1.01
0.04
1.9
1.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
54
551
0.98
0.03
2.1
2.2
ml
663.9
635.0
0.18
34
364
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
12
128
0.94
0.02
1.8
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
46
470
0.98
0.02
1.3
1.3
u/ml
0.2
1.4
2.23
20
194
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
44
430
1.02
0.02
1.8
1.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
148
0.95
0.02
5.7
6.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
50
510
0.98
0.02
1.5
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
17
163
1.04
0.01
1.1
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
21
204
1.03
0.00
1.8
2.5
ng/l
276.9
118.6
0.48
15
140
(3000475) Leukocytes [#/volume] in Synovial fluid
161
1604
1.00
0.00
1.7
1.6
e6/l
12718.6
14603.0
0.32
115
1157
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
18
178
1.01
0.00
2.4
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
14
136
1.03
0.00
1.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
56
565
0.99
0.00
5.3
3.6
u/ml
64.2
43.2
0.30
56
559
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
52
521
1.00
0.00
1.3
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
11
106
1.04
0.00
1.5
1.6
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
16
163
0.98
0.00
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
16
163
0.98
0.00
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
16
163
0.98
0.00
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
16
163
0.98
0.00
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
803
8030
1.00
0.00
4.2
4.4
%
32.1
32.2
0.09
579
5487
(3002621) Streptococcal DNAse B [Units/volume] in Serum
11
107
1.03
0.00
1.2
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
21
208
1.01
0.00
1.4
1.2
g/l
43.3
39.1
—
9
116
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
37
374
0.99
0.00
1.9
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
12
118
1.02
0.00
6.2
6.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
37
375
0.99
0.00
1.9
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
381
3810
1.00
0.00
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
20
198
1.01
0.00
1.6
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
51
0.98
0.00
1.6
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
8
81
0.99
0.00
1.1
1.2
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
60
1.00
0.00
4.3
5.1
—
—
—
0
0
(3009179) Lactate [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.0
—
1.8
—
0
5
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
20.8
—
0
6
(3027035) Albumin [Mass/time] in 24 hour Urine
6
69
0.87
0.00
1.3
1.3
—
577.7
—
0
10
(3043614) Bacteria identified in Aspirate by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017497) Pine Nut IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759632) Porphyrins [Mass/mass] in Stool
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
82
0.98
0.00
1.0
1.0
—
—
—
0
0
(3025315) Body weight
5
52
0.96
0.00
3.6
4.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
59
1.02
0.00
4.3
4.9
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint FE_STRICT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| FE_STRICT | 3.574 [3.23, 3.96] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.063 |
During the follow-up period (1.1.1998 — 31.12.2019), 9830 out of 29202 females with FE_STRICT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| FE_STRICT | 3.485 [3.14, 3.87] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 12596 out of 33557 males with FE_STRICT died.
Mortality risk
Mortality risk for people of age
years, who have FE_STRICT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.289% | 0.634% |
| 5 | 1.789% | 3.581% |
| 10 | 4.845% | 8.1% |
| 15 | 9.14% | 14.981% |
| 20 | 15.75% | 24.808% |
Relationships between endpoints
↥Index endpoint: FE_STRICT – Focal epilepsy, strict definition
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data